All profiles

Organization
Organization: Society for Evidence-Based Gender Medicine (SEGM) [EIN 84-4520593]
Logo of Society for Evidence-Based Gender Medicine, from https://en.wikipedia.org/wiki/Society_for_Evidence-Based_Gender_Medicine, used for identification [image page1]

Society for Evidence-Based Gender Medicine

EIN 84-4520593

Anti-trans advocacy group opposing gender-affirming care

At least $3.1Mreceived on fileIRS Form 990 filings · 7 funders
At least $110Kgiven on fileIRS Form 990 filings · 2 recipients
29documented ties29 names on file
15people with a direct roleofficers, directors, founders, staff

An advocacy organization that campaigns against gender-affirming care; its "evidence-based" name does not make its rhetoric good faith, and the evidence brief documents the case for care. It appears here through clinicians and writers who describe themselves as its advisors, and through its funders.

Sources: IRS Form 990 e-file returns, EIN 84-4520593 (ProPublica Nonprofit Explorer, 2).

Money received

Grants as filed; the amounts are a lower bound:

  • Donor-advised fund sponsors (pass-throughs; donors undisclosed): $3,042,257 in 20 rows from 10 sponsors, TY2021-2025; the sponsors and amounts are listed below. DonorsTrust's $500,000 is TY2024, object 202513179349312256, "for general operations".
  • Edward Charles Foundation (EIN 26-4245043, 501(c)(3)): $100,000, TY2021, "CHARITABLE GIFT" (object 202230329349301233); the only non-donor-advised-fund funder among the filed grant rows, before the political-committee payment and the Edelman Family Foundation grant listed below.
  • Funders as filed on the grantors' returns; each amount is at least that much (a floor), and nothing is added across datasets. Source: IRS Form 990 e-file grant rows (ProPublica Nonprofit Explorer, 2). A grant shows money moved for the filed purpose, not an anti-trans purpose.
    • Donor-advised funds and community foundations (pass-through; underlying donors undisclosed): $3,042,257 in 20 rows from 10 sponsors, recounted by the recipient EIN. The lists overlap; do not add. By sponsor (IRS Form 990 Schedule I grant rows, recipient EIN 84-4520593): Fidelity Charitable 4 rows, $1,653,775 (one row of $363,500, period 2022-06-30, is on two returns, objects 202321309349304807 and 202430459349302913, and is counted once); DonorsTrust 1 row, $500,000; Jewish Communal Fund 1 row, $500,000; National Philanthropic Trust 1 row, $150,250; Vanguard Charitable 4 rows, $138,500; PayPal Charitable Giving Fund 3 rows, $44,339; American Online Giving Foundation 3 rows, $32,293; T Rowe Price Program for Charitable Giving 1 row, $10,000; Schwab Charitable Fund 1 row, $7,000; The Minneapolis Foundation 1 row, $6,100.
    • Further funders are not listed here.
  • Dave Yost for Ohio (candidate committee, id CAN-12822, candidate David Yost, office Governor, Republican, as filed) $300,000 (2026-04-17, purpose as filed "CONTRIBUTION", Ohio semiannual report of July 2026, line type "31-B Stmt of Expenditures", report key 513319756). This is a row in the committee's own report of expenditures (a payment out); the payee is recorded without an identifier, as Society for Evidence-Based Gender Medicine, Twin Falls, ID, and is matched to SEGM by name and by city and state on the IRS exempt-organization record for EIN 84-4520593 (Twin Falls, ID) (Ohio Secretary of State campaign finance reports, report key 513319756). The largest single rows are two of $500,000 (DonorsTrust and Jewish Communal Fund, listed above).
  • Same-day payments in the same report: on 2026-04-17 the committee's report lists seven expenditure rows, all with purpose as filed "CONTRIBUTION", totalling $1,500,000: Ethics and Public Policy Center, DC, $650,000; Do No Harm, UT, $350,000; Society for Evidence-Based Gender Medicine, ID, $300,000; and $50,000 each to Founding Freedoms Law Center (VA), Freedom Foundation (OR), True North Legal (MN) and Wisconsin Institute for Law & Liberty (WI). No row carries a payee identifier. The Ethics and Public Policy Center row (Washington, DC) and the SEGM row (Twin Falls, ID) match the IRS records for EIN 52-1162185 and EIN 84-4520593 by city and state; the Do No Harm row gives a Utah location, while the IRS record for EIN 87-4701865 gives Glen Allen, VA, so that match is by name only; the four $50,000 payees are checked in a later item. The same report lists 158 expenditure rows in all, totalling $1,831,171.86; the 2026-04-17 rows are the largest of them. Later rows in the report are $24,923.51 each to the Ohio House Republican Organizational Committee and the Republican Senate Campaign Committee and $16,615.67 each to five other Republican campaign committees, all dated 2026-06-15 (Ohio Secretary of State campaign finance reports, report key 513319756).
  • The four $50,000 payees of 2026-04-17, checked against identifiers (the report rows carry none, so each match rests on the name and city or state as filed; Ohio Secretary of State report key 513319756):
    • Wisconsin Institute for Law & Liberty, Milwaukee WI (row 15514390): matches the IRS record for EIN 45-1606079 (Wisconsin Institute for Law & Liberty Inc, Milwaukee WI, 501(c)(3), ruling 2011-12) by name, city and state (IRS exempt-organization master file).
    • True North Legal, St Paul MN (row 15514342): no IRS record under that name. Its own site says it is "an initiative of Minnesota Family Council" (3); Minnesota Family Council is IRS EIN 41-1863170, a 501(c)(4) in Saint Paul MN with TY2024 revenue of $248,131. The match to that EIN rests on that statement and the city only. See the Minnesota Family Council page.
    • Founding Freedoms Law Center, Richmond VA (row 15514288): no IRS record under that name. Its About page calls it "the legal arm of The Family Foundation" (4); The Family Foundation of Virginia is IRS EIN 52-1425355, a Richmond VA 501(c)(3). The match rests on that statement and the city only. See the Family Foundation of Virginia page.
    • Freedom Foundation, Salem OR (row 15514289): "Freedom Foundation" is a registered name of Evergreen Freedom Foundation, EIN 94-3136961, an Olympia WA 501(c)(3) with TY2024 revenue of $21,450,375 and a stated purpose, in its Oregon DOJ charity registration, "To advance individual liberty, free enterprise, and limited, accountable government" (Colorado and Oregon charity registries and IRS Form 990 e-file). Oregon's business registry lists Evergreen Freedom Foundation (registry number 113094692, a Washington nonprofit registered in Oregon on 2015-07-22) with a Salem, Oregon post office box as its mailing address, the same box and city that the Ohio row gives for "Freedom Foundation"; OPB reported in 2018 that the Olympia-based group's Oregon arm works from Salem (Oregon Secretary of State registry data, 5; 6). The Ohio row carries no identifier, so the match to EIN 94-3136961 rests on the name, the city and the post office box.
    • No news report or statement about any of the seven payments turned up in web searches on the committee, the payees and the campaign's funds.
  • Context of the campaign: Dave Yost, Ohio Attorney General, suspended his campaign for governor on 2025-05-16, a week after the Ohio Republican Party endorsed Vivek Ramaswamy; he said he would serve as attorney general until his term ends in January 2027 (national news wire copy, 2025-05-16, 7). That article does not mention campaign funds or gender-affirming care. The committee's July 2026 report is dated after the suspension.
  • Ohio rule on surplus funds: Ohio Revised Code 3517.109 lists, as ways to dispose of excess campaign funds, payment to the state treasurer for the election integrity commission fund, refunds to contributors, or a donation to a tax-exempt organization described in section 501(c) of the Internal Revenue Code, with a report of the disposal (8). The section ties the deadline to the candidate's filing date for office; whether it governed this payment is not established, and the records do not say which provision, if any, the committee relied on.
  • Yost's office on care for trans youth: the Attorney General's office, with the State of Ohio and the State Medical Board, is the defendant-appellant in Ohio Supreme Court No. 2025-0472, defending House Bill 68, Ohio's ban on gender-affirming medical care for minors; oral argument was on 2026-03-24, about three weeks before the payments (Court News Ohio preview, 9). That is a documented public position of the office.
  • No statement from SEGM, the committee or Yost about the payment was found, and no Ohio news coverage of it was found in the searches made.
  • Revenue as filed: TY2020 $199,566; TY2022 $229,683; TY2023 $822,161; TY2024 $1,647,130 (IRS Form 990 e-file, EIN 84-4520593; ProPublica Nonprofit Explorer, 2). The return for 2021 (object id 202203189349305115) gives total revenue $793,975, total expenses $151,534 and total assets $769,095; the expenses of $984,539 and assets of $1,231,524 are the 2024 figures (object id 202513209349300536). InfluenceWatch, citing Candid data, also reports no government funding and no employee salaries in 2023. (10; an advocacy-research source).
  • Edelman Family Foundation: InfluenceWatch, citing Candid, reports a $100,000 grant in 2023 that supported three projects, including an evaluation of the WPATH Standards of Care 8 (the foundation's own return lists it; see the attached-list item below).
  • Fidelity Charitable: the same $363,500 grant, period 2022-06-30, appears on two different SEGM-side returns (objects 202321309349304807 and 202430459349302913); it is counted once in the $1,653,775 above (IRS Form 990 e-file, EIN 84-4520593; ProPublica Nonprofit Explorer, 2).
  • Yost committee payee "True North Legal, St Paul MN" ($50,000, 2026-04-17, row 15514342): a Schedule R entry on Minnesota Family Institute's returns for the periods ending 2022-09-30, 2023-09-30, 2024-09-30 and 2025-09-30 lists True North Legal PLLC (EIN 92-2096361, Saint Paul, MN), purpose as filed "LEGAL SERVICES", as a disregarded entity controlled by Minnesota Family Institute (EIN 41-1439560) (IRS Form 990 e-file, EIN 41-1439560, objects 202342269349302129, 202412279349301776, 202532279349300048, 202602299349301185). The Ohio payee row carries no identifier, so it is matched to that entity by name and city only. See the profiles of Minnesota Family Council and Minnesota Family Institute.
  • Yost committee payee "Founding Freedoms Law Center, Richmond VA" ($50,000, 2026-04-17, row 15514288): the organization's own donation form is titled "C3 Donation Form - FFLC" and its text opt-in line reads "I want to receive text messages from The Family Foundation" (11). The Virginia registry holds one corporation, The Family Foundation (number 02770782, formed 1985-10-15, status as recorded "Pendinact"), with "Founding Freedoms Law Center" as a former name (Virginia State Corporation Commission business registry); that row carries no EIN, and Schedule R of The Family Foundation of Virginia (EIN 52-1425355) does not list Founding Freedoms Law Center (see the profile of The Family Foundation of Virginia). No identifier ties the payee row to an EIN.
  • The seven payments in the Dave Yost for Ohio committee's semiannual report (report key 513319756), all dated 2026-04-17 and all with the purpose "CONTRIBUTION", total $1,500,000: Ethics and Public Policy Center $650,000, Do No Harm $350,000, Society for Evidence-Based Gender Medicine $300,000, and $50,000 each to Founding Freedoms Law Center, Freedom Foundation, True North Legal and Wisconsin Institute for Law & Liberty (Ohio Secretary of State campaign-finance filings, 12). The payees carry no identifiers.
  • The latest report by the Yost committee on file is the July 2026 semiannual report (Ohio Secretary of State campaign-finance filings, 12).
  • The Edelman Family Foundation filer with EIN 37-6624335 (the foundation that gave Do No Harm $1,000,000 in TY2022) filed its grants for TY2023 and TY2024 as a single line each, "SEE ATTACHED" ($10,366,636, object id 202423209349103907, and $13,907,577, object id 202513219349108971), without a list in the return data, so no grant row to SEGM can appear from it; the attached list of the TY2023 return shows the SEGM grant (see the attached-list item below) (IRS Form 990-PF e-files, EIN 37-6624335; ProPublica Nonprofit Explorer, 13).
  • State Policy Network (EIN 57-0952531) paid the Edward Charles Foundation (EIN 26-4245043, Beverly Hills CA), the foundation listed above as a funder of $100,000 in TY2021, $45,000 in 1 grant row (period ending 2025-12-31, purpose as filed "EDUCATION"), matched by recipient EIN. The return does not say whether any of it reached the Society for Evidence-Based Gender Medicine (IRS Form 990 e-file, giver EIN 57-0952531, object id 202612549349300726).
  • Edward Charles Foundation (EIN 26-4245043, Beverly Hills CA): the Stand Together Trust paid it $1,433,000 in TY2021 ("General Operating Support", object id 202233199349324393); the foundation's own returns in the records (TY2017 to TY2024) show total revenue between $10,864,095 (TY2019) and $67,600,579 (TY2024). No filing reviewed here states that the Trust's grant funded the $100,000 grant to SEGM (IRS Form 990 e-files, EIN 26-4245043).
  • The Edward Charles Foundation (EIN 26-4245043), which paid the $100,000 (TY2021, "CHARITABLE GIFT"), is a fiscal-sponsorship platform: its own site calls it "the premiere outsourced back-office platform for fiscal sponsorship and donor advised funds", and its returns list dozens to about 200 grant rows a year (43 to 204 rows per return); the row does not show which sponsored project directed the gift. [14; IRS Form 990 e-file, EIN 26-4245043, object 202230329349301233]
  • The Edward Charles Foundation's return for the year ending 2021-06-30 says that it makes a grant on the information provided by 'the granting fiscal sponsee' and requires a grant agreement for a substantial grant (Schedule I, Part I, line 2); the sponsee that requested the $100,000 to SEGM is not named. [Form 990, EIN 26-4245043, period 2020-07-01 to 2021-06-30, object 202230329349301233, 15

SEGM's FAQ, under "How is SEGM funded?", says it "relies on the generosity of individuals and charitable foundations" and names no donor (16).

  • Other years as filed: 2020 expenses $72,912, assets $126,654; 2022 expenses $442,839, assets $555,939; 2023 expenses $809,167, assets $568,933, contributions $773,296 (IRS SOI extract); 2024 expenses $984,539, assets $1,231,524 (returns 202133199349322848, 202323179349310692, 202423189349302147, 202513209349300536). The returns carry no donor rows. [IRS Form 990 e-file and SOI extract, EIN 84-4520593; ProPublica Nonprofit Explorer, 17
  • When a report could follow: SEGM's returns are on a calendar year, so the 2026-04-17 payment falls in the year ending 2026-12-31, whose Form 990 is due the 15th day of the fifth month after year end (2027-05-15) unless extended by six months (IRS, "Annual exempt organization return: due date"); SEGM's latest return reviewed is for 2024. The Yost committee's last report in the Ohio files is the Semiannual (July) 2026 report (key 513319756, activity 2026-01-05 to 2026-06-30; the committee record gives a balance at last report of $528,150.55 and 55 reports); the Ohio Secretary of State's 2026 calendar sets the Annual report for 2027-01-29, covering activity through 2026-12-31. [Ohio Secretary of State campaign finance files; Ohio campaign finance reporting calendar 2026 (SOS 0559, 11/2025); 18
  • Ohio Revised Code 3517.109, read on the state's code site: a committee may dispose of an excess amount by giving it to the treasurer of state, refunding contributors, or giving it to a corporation exempt from federal income tax (division C); disposal is due "not later than the filing date for that office" (division B), and a report of the disposal "shall be filed by the seventh day following the filing deadline" (division E(1)); the section sets no deadline tied to a candidate withdrawing. Whether the section governed the 2026-04-17 payments is not established. [19
  • The seven payee rows of 2026-04-17 carry business addresses in the Ohio file. Compared with filed addresses: the Ethics and Public Policy Center row and the SEGM row each carry the street address on that body's IRS master-file record and on every return read (EINs 52-1162185, 84-4520593); the Wisconsin Institute for Law & Liberty row (EIN 45-1606079) carries the street address on its master-file record and 2025 return only (its returns for 2018 to 2024 give a different street, and those for 2012 to 2017 another); the Founding Freedoms Law Center row carries the Richmond street address of The Family Foundation of Virginia on its master-file record and 2019-and-later returns (EIN 52-1425355); the True North Legal row carries the St Paul street address of Minnesota Family Council and of Minnesota Family Institute on their master-file records (EINs 41-1863170 and 41-1439560); the Do No Harm row gives Salt Lake City, UT, which is the mailing address on Do No Harm's own contact page, while the IRS record for EIN 87-4701865 gives Glen Allen, VA; the Freedom Foundation row (a post office box in Salem, OR) gives the same box and city as the mailing address in Oregon's business registry for Evergreen Freedom Foundation (registry number 113094692; the IRS record for EIN 94-3136961 gives a post office box in Olympia, WA), and the Freedom Foundation's home page shows that EIN in its footer and no office address. No row carries an identifier, so each match remains a name-and-address match. [Ohio Secretary of State file, report key 513319756; IRS exempt-organization master file and Form 990 e-file returns; 20; 21
  • The grantor text in the InfluenceWatch table (citing Candid) reads "Edelman Family Foundation C/o Mariner Wealth Advisors", 2023, $100,000, "To support three projects: (1) the Evaluation of "Standards of Care 8" by WPATH, (2) Systematic Review of Evidence ... commissioned from McMaster University, and (3) Physician Education Course, provided in collaboration with Medscape". That wording matches the filer name "Edelman Family Foundation C/O MARINER WEALTH ADVISORS" (New York, NY, EIN 37-6624335), not the other Edelman-named filers in the records (EINs 72-1271228 Towson MD, 11-3455820 Lawrence NY, 87-4060354 Weston FL, 20-3921425 Jupiter FL, 59-7109743 Jacksonville FL, 36-7184921 Chicago IL, 81-1077915 Olathe KS). The foundation's TY2023 return (object id 202423209349103907) files its grants as one line, "SEE ATTACHED" ($10,366,636), so no grant row to SEGM is visible in the return data; the attached list (next item but one) shows the grant. [10; IRS Form 990-PF e-file, EIN 37-6624335]
  • Edelman Family Foundation, TY2023 return: The attachment to the Edelman Family Foundation's TY2023 Form 990-PF is not part of the return as filed electronically. The return (EIN 37-6624335, object id 202423209349103907, 23 pages in the PDF rendering) shows in Part XV line 3 "Grants and Contributions Paid During the Year or Approved for Future Payment" a total of $10,366,636 and, as the recipient lines, "SEE ATTACHED" (recipient status "PC", relationship "NONE"); no recipient name, amount or purpose appears in the electronic return's pages; the attached list is in the IRS public copy (next item). (Edelman Family Foundation c/o Mariner Wealth Advisors, Form 990-PF TY2023, 22)
  • Edelman Family Foundation, TY2023 attached list: the foundation's attached list of grants paid itself shows Society for Evidence-Based Gender Medicine Corp, Twin Falls, ID, $100,000 (2023-04-04), purpose as filed "To support three projects: (1) the Evaluation of "Standards of Care 8" by WPATH, (2) Systematic Review of Evidence, commissioned from McMaster University, and (3) Physician Education Course, provided in collaboration with Medscape" (IRS Form 990-PF, EIN 37-6624335, tax year 2023, object id 202423209349103907, attached list "Part XIV - 3 - Grants and Contributions Paid During the Year", page 22 of the IRS public copy, 23). Matched by name and place (Twin Falls, ID, the city on SEGM's IRS record). The return itself documents the grant that InfluenceWatch's table also reports. SEGM's attacks on gender-affirming care are anti-trans rhetoric dressed in medical language; this purpose line shows the foundation paying for an "evaluation" aimed at the WPATH standards, a commissioned evidence review and a physician course from that organization.

Money given

  • SEGM paid $10,000, purpose as filed "SPECIFIC EVENT", to United Charitable (EIN 20-4286082, Ashburn VA; a donor-advised-fund sponsor) in the year ending 2023-12-31 (object id 202423189349302147), the only grant-paid row on SEGM's returns in the records. [IRS Form 990 e-file, EIN 84-4520593; ProPublica Nonprofit Explorer, 17

People on file

Stella O'Malley is described as "Clinical Advisor in the Society for Evidence-Based Gender Medicine" in The Critic's contributor bio (publisher bio, undated). SEGM's own About page, listed below, does not list her; SEGM's studies page, in its account of the letters to the editor of The Lancet Child & Adolescent Health answering its editorial on US bills limiting care for minors, calls her "a SEGM advisor" (24, read). SEGM's own About page lists, as stated: Evgenia (Zhenya) Abbruzzese, co-founder and senior advisor (US); William Malone, MD, co-founder and founding board member; Roberto D'Angelo, president and founding board member (Australia); Julia W. Mason, founding board member; and advisors Michael Biggs (University of Oxford), Richard Byng (University of Plymouth), Anna Hutchinson (London clinical psychologist), Sarah Mittermaier, Karla Solheim (Iowa OB/GYN) and Anastassis Spiliadis (25). The page says SEGM is "free from political, ideological, religious, or financial influences"; that statement is SEGM's own and does not change the funding record above.

  • Alison Clayton, MBBS, PhD, is listed as a speaker at SEGM's 2025 Berlin conference ("Youth Gender Distress", 11 to 14 September 2025): the agenda gives "Social Transition (Alison Clayton)" for Thursday 11 September at 10:45 (SEGM, 26, read). SEGM's page for its Washington, DC conference "Rethinking Youth Gender Medicine" (5 to 7 November 2026) lists her as "Consultant Psychiatrist & Specialist Psychotherapist" and gives her talk as "Breaking Down the Dutch Health Council Report" (SEGM, SEGM, Washington conference programme for 5–7 November 2026). SEGM's About page list of advisors does not include her (25, read).
  • Alison Clayton is the sole author of a Letter to the Editor, "Gender-Affirming Treatment of Gender Dysphoria in Youth: A Perfect Storm Environment for the Placebo Effect" (Archives of Sexual Behavior, published 14 November 2022, 27, read). The article gives her affiliation as the School of Historical and Philosophical Studies, University of Melbourne, states "No funding was received for this paper", and, under conflict of interest, "The author is affiliated with the Society for Evidence-based Gender Medicine. There are no financial conflicts to interest to declare." Its reference list includes a 2021 commentary on puberty blockers in Child and Adolescent Mental Health by Clayton, William J. Malone, P. Clarke, Julia Mason and Roberto D'Angelo (the reference entry as printed in the article). The article is anti-trans advocacy framed as a methods critique of care for trans youth. SEGM's own write-up of it (page of 7 December 2022, 28, read) calls her "a researcher and practicing psychiatrist (who is also affiliated with SEGM)"; that description is SEGM's own and the page gives no title or dates.
  • Anna Hutchinson is listed among SEGM's "Featured 2025 Conference Speakers" for the Berlin conference, and on the Washington, DC 2026 conference page as "Clinical Psychologist and Clinical Director", where a session "You Know More Than You Think: Theory and Practice of Working With Gender Distressed Youth" is listed for her with Anastassis Spiliadis (SEGM, 26 and SEGM, Washington conference programme for 5–7 November 2026). SEGM's About page describes her as Clinical Director at the Integrated Psychology Clinic in London who worked at the Tavistock GIDS "From 2013 to 2017" (25, read; SEGM's own text).
  • Anastassis Spiliadis is listed among the featured Berlin 2025 speakers, with the talk "Exploring Gendered Embodiment in Systemic & Family Psychotherapy" on Sunday 14 September 2025 at 10:45 (SEGM, 26, read), and on the Washington, DC 2026 page as "Family & Systemic Psychotherapist; PhD(c), University of Essex" (SEGM, Washington conference programme for 5–7 November 2026). SEGM's About page says he served "From 2015 to 2019" as "a psychotherapist, supervisor, and trainer at the Tavistock GIDS" and "introduced the concept of Gender Exploratory Therapy in 2018" (25, read; SEGM's own text, not independently confirmed).
  • Evgenia (Zhenya) Abbruzzese is listed among the featured Berlin 2025 speakers; the agenda gives her the first talk "A Brief History of Pediatric Gender Medicine" on Thursday 11 September 2025 at 9:30, and the Washington, DC 2026 page lists her as "Co-Founder, SEGM" and as moderator of a session (SEGM, 26 and SEGM, Washington conference programme for 5–7 November 2026). SEGM's Spotlight page of 22 October 2024 on the "Yale" critique of the Cass Review states, as a declaration of interest, "One of the authors of the ADC paper, Evgenia Abbruzzese, is a Senior Advisor for SEGM" (29, read).
  • Zhenya (Evgenia) Abbruzzese: SEGM's About page lists her as "Co-founder and Senior Advisor (US)", a "healthcare researcher" who "led analytics efforts for a major insurer" before co-founding SEGM and whose paper "The Myth of 'Reliable Research' in Pediatric Gender Medicine" is described there as having "mounted a significant challenge" (SEGM, 25, read). Undark (20 May 2024) describes her as "a health care researcher with a background in health economics and a SEGM co-founder" who contacted Julia Mason and Malone while looking to create the group, who asked an evidence-methods researcher to work for SEGM, and who spoke with the reporter at a London conference organized by the Clinical Advisory Network on Sex and Gender (30, read).
  • SEGM's own page reproducing an Economist article of 2 December 2024 on the US Supreme Court case on Tennessee's ban on puberty blockers and hormones (SEGM page date December 22, 2024; 31, read) quotes "Zhenya Abbruzzese of the Society for Evidence-Based Gender Medicine" as saying that those pushing adolescent transitioning are "trying to appropriate the protections of sex, while stripping away the meaning of sex, and substituting it with gender identity". The statement is anti-trans rhetoric.
  • SEGM's own list of studies (24, read) gives Abbruzzese as an author of three items: "Reconsidering Informed Consent for Trans-Identified Children, Adolescents, and Young Adults" (Levine, Abbruzzese, Mason, Journal of Sex & Marital Therapy, 2022); "The Myth of 'Reliable Research' in Pediatric Gender Medicine" (Abbruzzese, Levine, Mason, Journal of Sex & Marital Therapy, 2023); and "Current Concerns About Gender-Affirming Therapy in Adolescents" (Levine, Abbruzzese, Current Sexual Health Reports, 2023). The list gives authors and journal only.
  • Julia W. Mason, MD, is listed on SEGM's About page as "Founding board member (US)", with the bio line "a board-certified pediatrician and Fellow of the American Academy of Pediatrics" (SEGM, 25, read). SEGM's open letter dated 19 December 2020 ends with a sign-off "on behalf of SEGM Board of Directors" that includes "Julia Mason, MD" (SEGM, 32, read).
  • Julia Mason's own writing: a KevinMD article published 7 October 2019 under her by-line as a pediatrician says "I'm worried about the rapidly rising numbers of children being diagnosed as transgender", that she is "now wary of referring to the gender clinic" and that "there are hundreds, probably thousands of 'detransitioners'" (33, read). These are anti-trans claims.
  • Genspect's post of 3 May 2025 describes Julia Mason as a founding member of SEGM and reports that she spoke at the Bigger Picture Conference in Killarney, arguing that trust in the American Academy of Pediatrics is unfounded (Genspect, 34, read; Genspect's own post).
  • Karla Solheim, MD, is listed on SEGM's About page as "Advisor (US)" among the 2026 advisors. SEGM's bio says she is a board-certified obstetrician/gynecologist who chaired the Iowa Section of ACOG from September 2024 through March 2026 (SEGM, 25, read; the dates are SEGM's own).
  • Karla Solheim wrote an essay in The Free Press (page date "08.05.26") saying she served as chair of the Iowa section of ACOG "for a year and a half" and that in March an ACOG vice president told her to resign as chair or stop publicly criticizing ACOG's endorsement of WPATH's guidelines; the essay's author note calls her "the lead medical advisor for the LGB Courage Coalition" (35, read). The account of the meeting is her own. The essay's claim about the evidence base for gender medicine is anti-trans rhetoric made in bad faith.
  • Richard Byng, MB BCh, MPH, PhD, MRCGP, is listed on SEGM's About page as "Advisor (UK)"; the bio says he works in general practice and in a mental health team for young people in Plymouth and is Professor in Primary Care Research at the University of Plymouth (SEGM, 25, read). The University of Plymouth's staff page lists him as Professor in Primary Care Research and PenARC Deputy Director, Peninsula Medical School, leading the Community and Primary Care Research Group since 2009 (36, read).
  • Richard Byng is one of four authors of "Gender incongruence in children, adolescents and adults", British Journal of General Practice 69(681):170-171, April 2019 (37; record on the University of Plymouth research portal, 38, abstract only). The abstract says that "a policy of active affirmation and treat or refer may lead to more people receiving medical interventions with uncertain outcomes", and also that patients' concerns should always be heard under human rights frameworks. The first claim is anti-trans rhetoric.
  • Roberto D'Angelo: the open letter of 19 December 2020 is signed "Roberto D'Angelo, SEGM President, on behalf of SEGM Board of Directors" (SEGM, 32, read), dating the presidency to at least that date; the About page gives "President and founding board member (Australia)" (25).
  • Sarah Mittermaier, MSc, is listed on SEGM's About page as "Advisor (US)"; the bio says she is a researcher on online spaces where young people encounter ideas about gender, with an MSc thesis, "Questions and doubts in online trans communities", through McGill University (SEGM, 25, read; bio as SEGM states it). She is listed as a speaker at SEGM's Berlin conference "Youth Gender Distress", 11 to 14 September 2025, with the talk "How Online Communities Shape Attitudes and Beliefs" on Friday 12 September at 11:45 in the Etiologies session (SEGM, 26, read).
  • Sarah Mittermaier wrote a post dated 29 April 2024, "Online trans communities as zero-gravity chambers", which she introduces as "My latest at Genspect"; it says such communities "serve as one of the first stops along a process of indoctrination" (39, read). The framing is anti-trans rhetoric.
  • Stephen Beck, MD, is named as a member of SEGM's board. SEGM's open letter "2020 Gender Medicine Highlights" (page date December 19, 2020) is signed "Roberto D'Angelo, SEGM President, on behalf of SEGM Board of Directors", followed by the names William Malone, MD; Julia Mason, MD; Marcus Evans; and Stephen Beck, MD (SEGM, 32, read). The Form 990 returns of Society for Evidence-Based Gender Medicine Corp (EIN 84-4520593) for tax years 2020 to 2024 list Stephen Beck as Treasurer with $0 compensation on Part VII (IRS Form 990 e-file, ProPublica Nonprofit Explorer, 2, read).
  • Stephen Beck is one of four authors of a Letter to the Editor, "Proper Care of Transgender and Gender-diverse Persons in the Setting of Proposed Discrimination: A Policy Perspective", Journal of Clinical Endocrinology & Metabolism 106(8):e3287-e3288, published 27 March 2021 (40; 41, read), with William J. Malone, Paul W. Hruz and Julia W. Mason. The letter gives his affiliation as "Private Practice", lists William Malone's as the Department of Medicine, Idaho College of Osteopathic Medicine, and ends "Disclosures: The authors have nothing to disclose". It argues that the Endocrine Society's position statement on puberty suppression, hormones and surgeries is "unsupported by the available evidence"; its claims are anti-trans rhetoric, and the evidence brief records prospective cohorts and large surveys that link puberty blockers and hormones to lower depression and suicidality in youth. SEGM's own list of studies (24, read) gives a second 2021 item with Beck as an author, "Puberty blockers for gender dysphoria: the science is far from settled", The Lancet Child & Adolescent Health, by Malone, D'Angelo, Beck, Mason and Evans; the list gives authors and journal only.
  • William Malone, MD, is the endocrinologist SEGM's About page lists as "Co-founder and founding board member (US)": it says he is board-certified, a graduate of Stanford University and New York University Medical School, in clinical practice since 2008 and "Assistant Clinical Professor of Endocrinology from the Idaho College of Osteopathic Medicine" (SEGM, 25, read). Undark, a science magazine, reports in a profile of 20 May 2024 that he attended the Endocrine Society's 2018 meeting, was "unsettled" by its guidelines, and "In 2019, he co-founded the Society for Evidence-Based Gender Medicine"; that a blog post he wrote for 4thWaveNow (a self-described community "that question[s] the medicalization of gender-atypical youth") caught the attention of Zhenya Abbruzzese, who "was looking to create a group for professionals with concerns about gender-affirming care"; and that "Malone, Mason, and three other clinicians formed the board" (30, read).
  • William Malone's public statements and actions on trans people, as Undark reports them (same article, read): in 2022 and again in 2023 he testified to Idaho legislators on bills that would criminalize prescribing puberty blockers or cross-sex hormones to young people, "in an individual capacity and not in relation to SEGM"; he petitioned the FDA to investigate off-label prescribing of puberty blockers; he co-signed that petition with a member of the American College of Pediatricians, a group the Southern Poverty Law Center designates a hate group (an attribution Undark gives to a critic's remark); he co-authored a Quillette article in which, Undark quotes, he "declared that 'no child is actually born in the wrong body'"; and, in July 2019, he told a YouTube interviewer who suggested the care could "neuter a generation" that people harmed by it would "start to stand up". Undark also reports that three anonymous donors gave more than $50,000 to SEGM through a GoFundMe campaign Malone created in December 2019 (Undark attributes this to a 2023 Southern Poverty Law Center analysis). These items rest on Undark's report.
  • SEGM's own page reproducing an Economist article of December 2020 on the Keira Bell ruling (page date December 12, 2020) quotes "Will Malone, an endocrinologist and director at the Society for Evidence-Based Gender Medicine, an international group of doctors and researchers", calling for "quality research into adolescent-onset dysphoria among girls" (SEGM, 42, read).
  • Marcus Evans: SEGM's page of 29 July 2022 on the closure of the Gender Identity Development Service ("World's Largest Pediatric Gender Clinic Shut Down Due To Poor Evidence, Risk of Harm and Operational Failures") opens a paragraph "Advisers to SEGM have been raising alarm about the unfolding scandal at the Gender Identity Development Service for some years" and goes on: "Marcus Evans served on the governing board of the Tavistock Trust, and in 2019 he resigned over the Trust's failure to heed warnings raised by staff within the clinic." The page does not use the word adviser of him in a sentence of his own; the paragraph presents him among SEGM's advisers. He is listed as a director on the 2020 return (43, read; the board and resignation statements are SEGM's).
  • J. Cohn, named on SEGM's page only by initial and surname, is described on SEGM's page of 16 June 2026, "Reassessing the Trevor Project's Suicide-Attempt Findings", in its closing note: "J. Cohn, one of the authors of the Trevor Project study's critique, is affiliated with SEGM." The page states an affiliation and no title or dates (44, read).
  • Colin Wright is described as an academic advisor to SEGM by the Manhattan Institute's biography of him (45, read).
  • Speakers listed on SEGM's conference pages. Berlin conference "Youth Gender Distress" (11 to 14 September 2025; 26, read): Alex Byrne is a featured speaker; SEGM's speaker page describes him as "Laurance S. Rockefeller Professor of Philosophy at MIT", author of "Trouble with Gender: Sex Facts, Gender Fictions" (46, read; SEGM's own description). He is also listed in the "History and aetiologies" session of SEGM's London conference page (47, read; no role given there). No other role at SEGM is shown.
  • Alexander Korte is listed with a talk of 12 September 2025, "Psychodynamic Considerations on the Etiology of Gender-Related Identity Conflicts" (26, read). A record of the Ludwig-Maximilians-Universität Munich library, a deposit of an article, places it in the "Clinic and Polyclinic for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy" of the Medical Center of the University of Munich, and lists him as author of a WELT article of 22 June 2022 titled "Kehren wir zurück zu einem Dialog. Dem Kindeswohl und der Wissenschaft zuliebe" (48, read). The 2025 German S2k guideline report lists Korte among members who left its commission in 2024. The steering group says he participated in meetings and votes through preparation of the public-comment draft, then submitted a ten-page methodological critique. It says he declined publication of that critique alongside the report. Guideline report49
  • André Leonhardt, PhD, is listed ("Research Psychologist, Medical University of Innsbruck") with a talk of 12 September 2025 (26, read); SEGM's speaker page describes him as a postdoctoral researcher in the Department of Child and Adolescent Psychiatry at the Medical University of Innsbruck whose research focuses on gender dysphoria, and who practises psychodynamic psychotherapy in private practice (46, read; SEGM's own description). He is listed as moderator of the Washington, DC 2026 session "Lived Experiences of Transition and Detransition" (SEGM, Washington conference programme for 5–7 November 2026).
  • SEGM's page for the London conference "Rethinking Youth Gender Medicine: First Do No Harm" (Central London; the page gives no year or date; jointly organised by the Clinical Advisory Network on Sex and Gender and SEGM, 47, read) lists Dr Aileen O'Brien as chair of the "Child and adolescent mental health" session (speakers listed: Anastassis Spiliadis, Prof. Céline Masson); the page gives no affiliation for her. Dr Celia Sadie is listed, with Dr Anna Hutchinson, for a talk on psychotherapeutic work with gender-distressed youth in the "Clinical perspectives" session; the page gives no affiliation for her either.
  • Chan Moruzi is listed on SEGM's Berlin 2025 programme as co-presenter with Ray Zhang on Thursday 11 September 2025 (26, read; the page gives no affiliation there). SEGM's Washington, DC 2026 programme (5 to 7 November 2026) lists Chan Moruzi on Day 3, Saturday 7 November, as "Independent Researcher, Adolescent Mental Health" (SEGM, Washington conference programme for 5–7 November 2026). McMaster University lists Chan Kulatunga Moruzi as a coauthor of the 2026 preprint “Systematic Reviews in Name Only? Misleading Evidence Assessments in Pediatric Gender Medicine.” McMaster University50
  • Prof. Celine Masson is listed on SEGM's London 2026 programme (the page gives no calendar date) on Day two with the talk "How can healthcare providers support young people questioning their gender identity, without fear?" (47, read; no affiliation given there). The Berlin conference program identifies Céline Masson as a professor of child and adolescent psychopathology at the University of Picardie Jules Verne. It credits her with cofounding the Observatoire la Petite Sirène in 2021. Berlin programme, p. 851
  • Dr David Pilgrim is listed on SEGM's Berlin 2025 programme as the speaker on Saturday 13 September 2025, 16:00, of "A Critical Realist Look at 'Gender Healthcare'" (26, read; no affiliation given). The London 2026 programme lists him as "Chair, Social and cultural influences" on Day two (47, read). In its notice for an October 28, 2025 webinar, the Clinical Advisory Network on Sex and Gender listed David Pilgrim among the panelists and identified him as a visiting professor at the University of Southampton. Webinar notice52
  • Baroness Dianne Hayter is listed on SEGM's London 2026 programme as giving the "Welcoming speech" (47, read; the page gives no affiliation there). On April 24, 2025, Baroness Hayter of Kentish Town told the House of Lords that she had repeatedly challenged the General Medical Council’s practice of registering doctors by gender. She argued that the practice affected women’s ability to give informed consent. House of Lords, archived 19 June 202553
  • Florian Zepf is listed among the featured speakers of SEGM's Youth Gender Distress conference, held 11 to 14 September 2025 in Berlin (26). The programme gives no talk, date or affiliation for him.
  • Jaco van Zyl is listed on the same programme as giving the talk "Trans Identification and the Dread of the Sexual" on Friday 12 September 2025 (Etiologies session). No affiliation is stated there.
  • Jilles Smids is listed on the same programme as giving the talk "Can Ethics 'Save' Pediatric Gender-Affirming Care, Now That We Agree the Evidence Is Weak?" on Saturday 13 September 2025 (Ethics session). No affiliation is stated there.
  • Joe Burgo is listed on the same programme as giving the talk "Psychic Retreat in Addiction, Autogynephilia, and Trans Identification" on Sunday 14 September 2025 (Psychotherapy session).
  • Dr Hannah Ryan is listed on the programme of the London conference "Rethinking Youth Gender Medicine: First Do No Harm", jointly organised by the Clinical Advisory Network on Sex and Gender and SEGM, as a speaker on "Adverse effects of hormonal interventions in gender medicine" (Research session, day one) and as a panellist in the "Looking to the future" discussion (day two) (47). The page gives no dates beyond "Day one" and "Day two", names "Central London" as the venue, and states no affiliation for her.
  • Hannah Barnes is credited on SEGM's page of 10 June 2025 as the author of an article in the New Statesman, which SEGM reproduced; the page says it appeared online on 27 May 2025 (54).
  • John Blythe is listed on the Berlin 2025 programme as giving the talk "Understanding the Intersection of Autism and Trans Identification" at 13:15 on Thursday 11 September 2025 (Evidence session) (26, read). The programme gives no affiliation for him. The printed program for SEGM’s September 2025 Berlin conference described John Blythe as a clinical psychologist directing a network of child and adolescent practices in New South Wales, Australia. Berlin programme, p. 1055
  • Jovanna Dahlgren is listed on the same programme as giving the talk "Known Unknowns: Anticipating Long-Term Risks of Cross-Sex Hormones in a Young Patient Population" at 11:45 on Thursday 11 September 2025 (26, read). The programme gives no affiliation for her.
  • Kaisa Kettula is listed on the same programme as giving the talk "Detransition in Adulthood" at 13:45 on Thursday 11 September 2025 (26, read). The programme gives no affiliation for her.
  • Ken Zucker, listed among the featured speakers, is named on the same programme as a member of the panel "Senior Clinicians Reflect on Current Treatment of Gender-Dysphoric Youth" at 15:30 on 11 September 2025, with Stephen Levine and Susan Bradley (26, read). SEGM's page of 2 October 2025, which reproduces a WELT article by Anna Kröning (translation approved by the author), describes "Kenneth J. Zucker" as a "Canadian psychologist" who was a speaker or participant at the Berlin congress (56, read).
  • Klaus Reinhardt is credited on the Berlin page with the video "SEGM 2025 Berlin Conference: Welcoming Address by Dr. Klaus Reinhardt" (26, read). The WELT article reproduced by SEGM names "Klaus Reinhardt, President of the German Medical Association" and says the German Society for Trans and Inter Issues (DGTI) criticised "the president of the German Medical Association for delivering opening remarks" at the congress, and that the BVT protested against the congress itself; it quotes him calling the circulation of named "wanted images" of conference participants "completely unacceptable" (56, read). SEGM's pages state no membership or role for him in SEGM.
  • Linda Hart is listed on the Berlin 2025 programme as giving the talk "Analysis of Contemporary Human-Rights Discourse in Pediatric Gender Medicine" at 12:00 on Saturday 13 September 2025, in the Ethics session (26, read). The programme gives no affiliation for her. Genspect’s report on the Berlin conference attributed to Linda Hart the argument that human rights are contextual and that no binding right to self-identification exists. Genspect conference report57
  • Lucy Johnstone is listed on the same programme as giving the talk "Taking on a Diagnostic Label" at 11:15 on Friday 12 September 2025, in the Etiologies session (26, read). The programme gives no affiliation for her. The Berlin program identifies Lucy Johnstone as a consultant clinical psychologist, visiting professor at London South Bank University and former director of the Bristol Clinical Psychology Doctorate. It credits her and Mary Boyle as lead authors of the Power Threat Meaning Framework, published by the British Psychological Society in 2018. Berlin programme, p. 1158
  • Maja Radobuljac is listed on the same programme as giving "Remarks from the European Society for Child and Adolescent Psychiatry" at 16:30 on Thursday 11 September 2025 (26, read). The programme gives no affiliation for her beyond the title of her remarks. The European Society for Child and Adolescent Psychiatry identifies Maja Drobnič Radobuljac as president of the Slovenian Association for Child and Adolescent Psychiatry and a member of the European society’s Policy Division. European society biography59
  • Michael Bailey is listed on the same programme as giving the talk "What Clinicians Need to Know About Autogynephilia" at 15:30 on Friday 12 September 2025 (26, read). The printed Berlin conference program identifies Michael Bailey as a Northwestern University psychology professor and the author of The Man Who Would Be Queen. Berlin programme, p. 1158
  • Dr Louise Irvine is listed on the programme of the London conference as giving "Introduction: Dr Louise Irvine, co-chair CAN-SG" at 9:30 on day one, as chair of the session "Evidence, uncertainty, and risk", and with the talk "Uncertainty and risk in gender treatments in adults: failings of the UK Levy review" (47, read). The page prints no date for the conference. The network's own About page lists "Dr Louise Irvine MBChB, MRCGP, DRCOG, MSc, General Practitioner" among "Some of our members" (60, read). The Clinical Advisory Network on Sex and Gender’s booking page dates its London conference with SEGM to July 5–6, 2026. It lists Louise Irvine’s session on prescribing hormones in general practice. Co-organizer’s booking page61
  • Mikael Landén is named on SEGM's home page, in the blurb of a media item, as one of the speakers at SEGM's first official conference, held in New York in October 2023: "a psychiatrist and researcher at Sweden's Karolinska Institute" (62, read). The same page carries an item, dated 30 July 2026 on the page, "Sex, Gender and Gender Identity: A Case for Conceptual Clarity", described as SEGM's review of "a newly published article in Acta Paediatrica" by "the Swedish psychiatrist Professor Mikael Landén", which argues about "the lack of definitional clarity around the concept of 'gender identity'" (62, read). The University of Gothenburg names Mikael Landén as professor and principal investigator in its affective disorders research group. University of Gothenburg63
  • Ray Zhang is listed on the Berlin 2025 programme as giving, with Chan Moruzi, the talk "Evidence Reviews for Puberty Blockers, Hormones, and Surgeries" at 11:15 on Thursday 11 September 2025, in the Evidence session (26, read). The programme gives no affiliation for him.
  • Moti Gorin is listed on the same programme as giving the talk "Ethical Healthcare vs. 'Buyer Beware': The Misuse of Autonomy in Pediatric Gender Medicine" at 14:00 on Saturday 13 September 2025, in the Ethics session (26, read). The conference's printed programme describes him as "Philosopher and bioethicist. He is Associate Professor of Philosophy at Colorado State University" (64, read). A University of Texas Southwestern continuing-education page lists him as speaker, with the same title, for an ethics grand rounds titled "Pediatric Gender Medicine: Evidence and Ethics" on 10 March 2026 (65, read). See the profile of LGB Courage Coalition.
  • Paul Salkovskis is listed on the same programme as giving the talk "Combining Social Identity and Cognitive Behavioural Theories to Understanding Stigmatization of Identity" at 9:00 on Friday 12 September 2025, in the Etiologies session (26, read). The University of Oxford's Department of Experimental Psychology page for the Oxford Gender and Wellbeing Research Group names him as co-leader with Kathryn Webb and as Professor of Clinical Psychology (66, archive copy of 2026-07-13). The same archive copy says the group's work "is supported by unrestricted grants from SEGM"; the page gives no amount or year.
  • Riittakerttu Kaltiala is listed on the same programme as giving the talk "Sociogenic Epidemics" at 13:15 on Friday 12 September 2025 (26, read). The conference's printed programme describes her as "Professor of adolescent psychiatry, leader of one of the two nationally centralized gender identity units for minors in Finland" (64, read). The same SEGM page, under "Other Events", says that in June 2023 "in partnership with Riittakerttu Kaltiala, Professor of Adolescent Psychiatry and Faculty of Medicine and Health Science Technology, SEGM helped to organize a conference at Tampere University in Finland on the subject of psychotherapeutic approaches to youth gender dysphoria" (26, read). She is also a named co-author of the conference report published in the bulletin of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), bylined "Professor of Adolescent Psychiatry, Tampere University; Chief Psychiatrist, Department of Adolescent Psychiatry, Tampere University Hospital, Finland" (67, read).
  • Paul Garcia-Ryan is listed on the same programme as giving the talk "Transition-Related Grief: Insights from Clinical Practice" at 15:00 on Sunday 14 September 2025, in the Psychotherapy session (26, read). The conference's printed programme describes him as "Executive director of Therapy First" who "works in private practice in New York City" and "authored an op-ed published by the Washington Post" (64, read). Therapy First's own About page says that in 2023, "under the leadership of Paul Garcia-Ryan", the organization "underwent a rebranding" (68, read). The organization's Form 990 for fiscal 2024 (filed as Therapy First Corporation, EIN 87-3936604) lists him as Executive Director (69).
  • Mikael Scott Bjerkeli is the author of "Treatment of young people with gender incongruence requires more than consent", which SEGM's page says "appeared on Aftenposten on November 17, 2025, and is translated and reproduced here with permission"; the byline reads "Executive Director, Harry Benjamin Resource Centre" (70, read). The article argues for mandatory psychiatric and psychological assessment in the clinical pathway for minors, revision of Norway's national guideline, and a national registry; these are the article's claims, and its case for gatekeeping care for minors, published by SEGM, is anti-trans rhetoric. it also calls the German 2025 guideline a "consensus-based document" whose "scientific quality does not meet the standards normally required for medical practice". His title is repeated in the byline of the IACAPAP bulletin report on SEGM's Berlin conference, where he is one of five named authors: "Executive Director, Harry Benjamin Resource Center, Oslo, Norway" (67, read). SEGM's page does not list him as a conference speaker.
  • SEGM's own article "Gender-Dysphoric Adolescents and Gender Transition Regret: What We Don't Know" (dated 2 November 2021; 71, read) says that "Another LTE, from a group of psychotherapists submitted by Stella O'Malley (a SEGM advisor), also took issue with the 1% regret rate", and that the letter recounted the changing practices in Sweden, Finland and the UK. This is SEGM describing Stella O'Malley as an advisor in a 2021 article; it is not a dated appointment. SEGM's About page (25, read) does not list her among its 2026 advisors. The description agrees with The Critic's contributor bio quoted above.
  • Sallie Baxendale is listed as a speaker at four SEGM conferences: New York 2023 (reported by Undark, not a SEGM page; the October 2023 conference is described in Undark, 30, read, which names her as "a professor of clinical neuropsychology at University College London" among its speakers), Berlin, 11 to 14 September 2025 (talk "Cognitive Bias and the Response to the Cass Report", Saturday 13 September, 26, read; and the printed Berlin programme, 64, read, which gives her as Professor of Clinical Neuropsychology at the UCL Queen Square Institute of Neurology), London 2026 (talk "Puberty blockers and the adolescent brain", 47, read), and Washington, DC, 5 to 7 November 2026 (talk "Wandering Rationales in Youth Gender Medicine" and a panellist in "Suppression, Distortion, and Censorship in Gender Medicine", SEGM, Washington conference programme for 5–7 November 2026; listed as Professor of Clinical Neuropsychology, University College London). Times Higher Education (15 October 2026, 72, read) reports she was shortlisted for the Maddox Prize and that she wrote an UnHerd article, which the report dates to two years before October 2026, describing three journals rejecting her review of puberty blockers and cognition; the report also notes that activist websites have labelled her "anti-trans". Her case against puberty blockers is anti-trans rhetoric presented as a neuropsychological concern; the account of rejected papers is hers, as the report gives it.
  • Scot Bradley Glasberg, MD, is listed as a speaker on SEGM's London 2026 page (talk "Breaking the Mold: How the American Society of Plastic Surgeons Decided to Put Evidence First", described there as "former chair of American Plastic Surgery Association"; 47, read) and on its Washington, DC page for 5 to 7 November 2026, which lists him as "Past President, American Society of Plastic Surgeons", gives the same talk, and has him moderate the panel "HHS Evidence Review Authors on the Status of Youth Gender Medicine Today" (SEGM, Washington conference programme for 5–7 November 2026). The London page prints the society's name as quoted; the DC page and NBC News give it as American Society of Plastic Surgeons. His own practice site calls him a past president of the society and of the Plastic Surgery Foundation (73, read; self-description). The society's position statement of 3 February 2026, "Position Statement on Gender Surgery for Children and Adolescents", addresses surgery for people under 19 and says the society had in August 2024 characterised the evidence base as "low quality/low certainty" (74, read); the statement does not name him. NBC News/AP (5 February 2026, 75, read) reports that the society recommended delaying chest, genital and facial gender surgery until age 19, citing "insufficient evidence", resting on the Cass Review and the 2025 HHS report, and quotes Glasberg, "a past president of the surgeons group", as having helped develop the statement. The same article says the statement is not a clinical guideline and the society did not conduct an independent evidence assessment, gives the American Academy of Pediatrics' and WPATH's responses (both keep their guidance), and reports that HHS officials praised the move, which came under federal pressure on providers, and that the American Medical Association agreed only in part; the recommendation is not a settled professional consensus. STAT reported that Glasberg, "a past president of the group", said the evidence is "low quality, low certainty", that the administration "didn't have a role in this", and that he would have voted for the guidance had he still been on the board (76, read). These are the outlets' reports of his words. Surgery on trans minors is extremely rare.
  • Sinead Helyar is listed on SEGM's London 2026 page as a speaker, talk "Pathways puberty blocker trial and why it does not comply with UK research regulations" (47, read; the page prints "Dr. Sinéad Helyar"). The Clinical Advisory Network on Sex and Gender's webinar page for 16 September 2025, "Puberty blocker research: ethics and challenges" (77, read), describes her as "a registered nurse and clinical researcher" who would speak on clinical trial regulations and ethical principles as they apply to the proposed puberty blocker trial.
  • Stefan de Villiers is listed on SEGM's Berlin page as the speaker for "How Assessments Benefit Clients and Removing Them Undermines Ethical Care", Saturday 13 September 2025, 11:30 (26, read). The printed Berlin programme (the dgppn.de address under Sallie Baxendale above, read, page of speaker biographies) describes him as a mental-health practitioner with a master's degree in social work from the University of Calgary who has worked in community mental health and private practice since 2018. The page does not say where he practises.
  • Stella Kingett is listed on SEGM's London 2026 page as chair of the session "History and aetiologies" and as giving the closing remarks, "Dr Stella Kingett, co-chair, CAN-SG" (47, read). The same page says the conference was "jointly organised by the Clinical Advisory Network on Sex and Gender and the Society for Evidence Based Gender Medicine".
  • Steven Montante is listed as a panellist in "Suppression, Distortion, and Censorship in Gender Medicine" (with Alex Byrne, Chan Moruzi, Lisa Littman and Sallie Baxendale, moderated by Alice Sullivan) on SEGM's Washington, DC page for 5 to 7 November 2026 (SEGM, Washington conference programme for 5–7 November 2026). The page prints no title or affiliation for him. The author-accepted manuscript of a 2025 systematic review of hormone therapy, commissioned by SEGM and McMaster University (78, read), lists "Steven Montante, MD" among its authors without an affiliation; whether he is the panellist is not shown.
  • Sue Evans is listed as a speaker at SEGM's Berlin conference of 11 to 14 September 2025: the agenda gives a talk "Family Consultation Model" by "(Sue Evans)" on Sunday 14 September 2025, 11:45, in the Psychotherapy session, and the featured speakers list prints "Susan Evans" (26, read). The page prints no institution for her and does not say the two spellings are one person.
  • Susan Bradley is listed on SEGM's Berlin 2025 agenda as a member of the panel "Senior Clinicians Reflect on Current Treatment of Gender-Dysphoric Youth", Thursday 11 September 2025, Evidence session (26, read; the panel and its other members are given in the entry for Ken Zucker above). The page prints no institution for her.
  • Thomas Thiel is the byline author ("Thiel, Thomas") of the Frankfurter Allgemeine Zeitung article of 8 October 2025 that SEGM states it "translated and reproduced fully, with permission" (79, read). The article reports that the venue of SEGM's Berlin conference was kept secret after calls online against attendees and that posters of three attendees circulated; it calls two professors "recognized experts in their field" and separately says thirteen professors criticised the German guideline. These are the article's words, not findings. The author of a news article is not a speaker or member of SEGM. Frankfurter Allgemeine Zeitung’s staff biography says Thomas Thiel joined the newspaper as a trainee in 2005, entered its arts and culture department two years later and covers research and higher education. Newspaper biography80
  • Tobias Banaschewski is listed under "Featured 2025 Conference Speakers" for SEGM's Berlin conference of 11 to 14 September 2025 (26, read); the page prints no institution, and no talk is printed under his name. The reproduced FAZ article identifies him as a professor of child and adolescent psychiatry and says he was among thirteen professors who criticised the German guidelines before they were agreed (79, read). The Central Institute of Mental Health in Mannheim lists Tobias Banaschewski as medical director of child and adolescent psychiatry and deputy director of the institute. Institute biography81
  • SEGM's own page for the conference "Rethinking Youth Gender Medicine" (Washington, DC, 5 to 7 November 2026; SEGM, Washington conference programme for 5–7 November 2026) lists no sponsors. It lists these speakers, with the descriptions it gives them: Forrest Smith, "Detransitioner, Writer, and Philosopher", in the session "Lived Experiences of Transition and Detransition" (Thursday 5 November, 13:15); Lisa Littman, "Physician-Scientist; President, Gender Dysphoria Institute", in "Detransition and Gender Dysphoria Trajectories" (Friday 6 November, 12:00) and in "Suppression, Distortion, and Censorship in Gender Medicine" (Saturday 7 November, 11:30); and Lisa Selin Davis, "Writer and Journalist, BROADview", moderator of the panel "How Institutions Failed Parents" (Thursday 5 November, 14:15). This is a programme listing, which shows who was scheduled and does not show that each session took place as listed.
  • The conference page's "Gender Dysphoria Institute" is, on the record, the Institute for Comprehensive Gender Dysphoria Research (EIN 85-2892486), whose return lists Lisa Littman as President (IRS Form 990 e-file, ProPublica Nonprofit Explorer, 82, read); the match to the conference page's name is an inference from the name and her title, which the page does not state.
  • Forrest Smith is described by Resilience Health Network's own Core Team page as "RHN Ambassador" (83, read), and a Genspect newsletter carries a guest post under his name dated 27 January 2026 (84, read).
  • BROADview, the publication named in Lisa Selin Davis's listing, describes itself as a newsletter on Substack about "the gender culture wars & the history, science, psychology & politics of gender nonconformity", with Lisa Selin Davis as its author (85, read). Her own site lists the books "Tomboy: The Surprising History & Future of Girls Who Dare to Be Different" and "Housewife" and bylines in The Guardian, Fast Company, The New York Times, Quartz and The Wall Street Journal (86, read); it says nothing on trans people.
  • Lisa Littman's paper "Rapid-onset gender dysphoria in adolescents and young adults: A study of parental reports" (PLOS One, 2018) recruited parents through websites that the journal's correction names: 4thwavenow, transgendertrend and Youth Trans Critical Professionals (with Parents of Transgender Children as a fourth); recruitment depended on whether parents believed their child showed a sudden or rapid onset of gender dysphoria. The journal's correction of 19 March 2019 states that the study did not record where participants first heard of it and that the populations it reached are unknown (87, read). The "rapid-onset gender dysphoria" idea is not recognized as a diagnosis by medical bodies (Wikipedia, offline copy of 2026-10-01, secondary: 88).
  • SEGM's own conference page ("Rethinking Youth Gender Medicine", "Charting a Path Forward", "November 5-7, 2026", Washington, DC) lists three speakers on its first-day session "When Science and Law Intersect" (Thursday 5 November, 16:15, moderated by Leor Sapir): Barrett Bowdre, "Solicitor General, Alabama Office of the Attorney General"; Josh Payne, "Founding Partner at Campbell Miller Payne, PLLC"; and Vernadette Ramirez Broyles, "President and General Counsel at Child & Parental Rights Campaign" (SEGM, Washington conference programme for 5–7 November 2026). A speaker listing shows an appearance, not a role in SEGM.
  • Barrett Bowdre: the Alabama Attorney General's office announced his appointment as Solicitor General on 5 November 2025, describing the post as "Alabama's chief appellate lawyer"; the release says he has been with the office since 2019 as Deputy Solicitor General and then Principal Deputy Solicitor General. In the release the Attorney General calls him "a driving force behind Alabama's landmark success" in what the Attorney General calls a scandal that "sought to normalize sex-change procedures for minors" (the Attorney General's wording; the release names no case). Source: 89 (read).
  • Josh Payne: the Federal Trade Commission's page for its 9 July 2025 workshop "The Dangers of 'Gender-Affirming Care' for Minors" lists him on "Panel 6: How Can the FTC Protect Families from Harm?" as "Partner, Campbell Miller Payne". The FTC's speaker biography says he is a Founding Partner of a Dallas, Texas firm "representing detransitioners and others harmed through gender-transition procedures". Sources: 90 and 91 (read). The Texas Secretary of State record for Campbell Miller Payne, PLLC gives file number 0804934519, formed 2023-02-20, status "Reinstated" (Texas registry).
  • Vernadette Ramirez Broyles: the Child & Parental Rights Campaign's own page of 19 June 2025 describes her as "President and General Counsel of the Child & Parental Rights Campaign (CPRC)" in a Fox News interview of 18 May 2025 on what the page calls "the transgender movement" in schools and government (92, read).
  • SEGM reproduced The Economist's article "A big transgender-rights case heads to America's Supreme Court" (published online 2 December 2024; SEGM posting date 22 December 2024, "reproduced in full ... with permission" per SEGM). The article describes Glenna Goldis as a lawyer and team member of Democrats for an Informed Approach to Gender (DIAG) and quotes her calling gender identity "a belief system that doctors and lawyers are falsely marketing to Americans as science" (her words; anti-trans rhetoric) (31, read). Being quoted in a reproduced article shows no working relationship with SEGM. The FTC's page for the 9 July 2025 workshop lists her on Panel 6 as "consumer protection attorney" (90, read).
  • SEGM reproduced The Times special report of 17 June 2022 (SEGM posting 1 July 2022) in which Kirsty Entwistle, described in the reproduced Times piece as a clinical psychologist who joined Leeds GIDS in 2017 and left after about a year, says she was "horrified" when her clinical partner argued a patient of 15 or 16 should start puberty blockers and says she left the service after being called a transphobe for asking questions (her account, as printed by The Times) (93, read). Being interviewed in a reproduced article shows no working relationship with SEGM.
  • Kathryn Webb, DClinPsych, is listed on SEGM's Washington, DC page for 5 to 7 November 2026 as "Clinical Psychologist; Senior Researcher, University of Oxford"; the programme lists her with Paul Salkovskis as presenter of "Toward a New Understanding of Gender Dysphoria" on day two (SEGM, Washington conference programme for 5–7 November 2026). The University of Oxford staff page describes her as a Senior Researcher on the "Oxford Gender Study" with Paul Salkovskis and as researcher and co-author for the Independent Review led by Alice Sullivan; it lists a 2023 article by her and others in the British Journal of Midwifery, 31, 512-518, titled "Trans and non-binary experiences of maternity services: cautioning against acting without evidence" (94, archive copy of 2026-07-11).
  • Ivan Florez, MD, PhD, is listed on the same page as "Professor of Pediatrics, University of Antioquia" and as a panellist on "The Trouble With Guidelines in Gender Medicine" on day three, with four others, moderated by Zhenya Abbruzzese (SEGM, Washington conference programme for 5–7 November 2026). Undark reported on 20 May 2024 that, when SEGM's co-founder first asked him to undertake research for the group, he looked into it, decided the request was worthwhile and "currently works with SEGM in an individual capacity" (30, read; his account as the outlet reports it).
  • Jonathan Moreno, "a professor emeritus at the University of Pennsylvania, who was an adviser to Barack Obama's bioethics commission", is quoted in The Economist's article of 5 May 2025 on the HHS report, reproduced on SEGM's site "with permission", as telling the British Medical Journal that the report cited reputable bioethical texts and presented a "plausible" analysis of ethics (95, read). A quotation in a reproduced article is not a role in SEGM.
  • Bob Withers, "a psychotherapist who has worked with young people who have regretted medical transitions", is quoted in The Economist's article of 17 November 2022, reproduced on SEGM's site under licence, on hormone prescribing to adults in England and on the NHS's listing as a signatory of a memorandum on conversion therapy (96, read). In a 2018 interview with spiked he says large numbers of children are transitioned unnecessarily (97, read); the claim is anti-trans rhetoric. No role in SEGM is shown.
  • SEGM's paper "Sex, Gender and Gender Identity: A Case for Conceptual Clarity" (SEGM, 30 July 2026) refers to "the early, brave voices of concern by the therapists Erica Anderson and Laura Edwards-Leeper" about clinical approaches (98, read). SEGM's Washington, DC 2026 programme lists Laura Edwards-Leeper, PhD, "Licensed Clinical Psychologist", as speaker on Day 1 (5 November 2026) in the session "Clinical Realities in a Culture War" (SEGM, Washington conference programme for 5–7 November 2026).
  • SEGM's Washington, DC 2026 programme lists Patrick Hunter, MD, "Pediatrician" (no affiliation given), as a panelist on Day 1 (5 November 2026, 13:15) in "Lived Experiences of Transition and Detransition" (SEGM, Washington conference programme for 5–7 November 2026). On November 14, 2025, Florida’s governor announced Patrick Hunter’s reappointment to the state Board of Medicine. The announcement identified him as a general pediatrician at Pensacola Pediatrics. Governor’s announcement99
  • SEGM's Washington, DC 2026 programme also lists Ray Yuan Zhang, PhD, with the affiliation "Evidence Bridge" (no title), as a panelist on Day 3 (7 November 2026, 13:30) in "The Trouble With Guidelines in Gender Medicine", with Florian Zepf, Ivan Florez, Kathleen McDeavitt and Moti Gorin, moderated by Zhenya Abbruzzese; the agenda gives the name as "Ray Zhang" (SEGM, Washington conference programme for 5–7 November 2026). SEGM’s Washington conference biography identifies Ray Yuan Zhang as the founder of Evidence Bridge and says he earned his doctorate in health research methodology at McMaster University. SEGM speaker biography100
  • SEGM's Washington, DC 2026 programme lists Sarah Jorgensen, PharmD, PhD, "Assoc. Research Scientist, Marshfield Clinic Research Institute", as speaker on Day 3 (7 November 2026, 14:30) with the talk "Prescribing Cascades Following Testosterone Initiation" (SEGM, Washington conference programme for 5–7 November 2026). Marshfield Clinic Research Institute’s scientific seminar program lists Sarah Jorgensen as the June 26, 2024 speaker on “Past, Present and Future Research Priorities.” It identifies her as an associate research scientist in clinical epidemiology and population health. Institute seminar programme101
  • 2025: the HHS report "Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices" (2025-11-19 edition) lists Evgenia Abbruzzese under "Society for Evidence-Based Gender Medicine" among its nine contributors, and SEGM's own About page lists her as Co-founder and Senior Advisor (US) (HHS report contributors page; 25). The report's footnote says "Contributor affiliations are listed for identification purposes only", so the listing is of an individual, not a statement of SEGM's role. The report's claims are anti-trans rhetoric; the evidence brief records published methodological critiques of it.
  • In June 2025 Alex Byrne identified himself as a co-author of the federal report on treatment for pediatric gender dysphoria and argued against medical transition for minors, according to Daily Nous. MIT’s student newspaper subsequently reported that an open letter signed by more than 200 people challenged his expertise and criticized his language about trans people. Daily Nous102 · The Tech103
  • On 2 December 2025 Aileen O’Brien signed the Clinical Advisory Network on Sex and Gender’s appeal against approval of the PATHWAYS trial. The letter asked regulators to pause recruitment pending peer review of the protocol. Letter to the regulators104
  • Celia Sadie and Anna Hutchinson signed a letter published by The Psychologist on 3 August 2022. The signatories criticized the British Psychological Society’s response to the closure of the Tavistock gender identity service and alleged that the service had harmed young people. Published letter105
  • A publisher’s biography accompanying Anna Kröning’s 2018 book listed her as an editor at Die Welt and Welt am Sonntag since 2011, covering education, migration and society. Book biography106
  • SEGM’s Washington conference biography names retired Massachusetts Supreme Judicial Court Justice Elspeth B. Cypher as a founding member of the Gender Critical Law Society. SEGM speaker biography100
  • Pamela Paul’s biography identifies her as a writer at large for The Wall Street Journal. It says she previously spent 14 years at The New York Times, including nine years as editor of its Book Review. Writer’s biography107
  • SEGM’s Washington speaker biography identifies Laura Edwards-Leeper as the founding psychologist of Boston Children’s Hospital’s Gender Multispecialty Service and as a former chair of the Child and Adolescent Committee of the World Professional Association for Transgender Health. SEGM speaker biography100

Anti-trans work: documented moments

Organization-level conduct, from the sources named. SEGM presents itself as a research society; its campaign against care for trans youth is anti-trans rhetoric made in bad faith. The evidence brief documents the case for care: evidence reviews rate the certainty for youth care as low, which describes a dispute about study design in a field where randomized trials are widely considered unethical and low ratings are common across pediatric medicine. It does not show that care should be restricted. The brief also sets out the published methodological critiques of the Cass Review and the 2025 HHS report, which SEGM-aligned writers cite.

  • 2019 to 2021: conceived in 2019 as an alternative to the WPATH Standards of Care, per Transgender Map (advocacy site; InfluenceWatch says formed in 2020); the tax exemption was issued in March 2021 (ProPublica Nonprofit Explorer, 2); the sources cited give no incorporation date.
  • 2019-09-07: SEGM filed a comment in its own name on the Department of Health and Human Services' proposed revision of the Section 1557 nondiscrimination rule (docket HHS-OCR-2019-0007). It supported the proposal to define sex for healthcare purposes and argued that medical records must keep "natal or biological sex" distinct from gender identity, calling the "conflation of sex and gender in medical records" a patient-safety risk (108).
  • 2020-12-19: in its end-of-year letter, "2020 Gender Medicine Highlights", signed by Roberto D'Angelo as SEGM President "on behalf of SEGM Board of Directors" (William Malone, MD; Julia Mason, MD; Marcus Evans; Stephen Beck, MD), SEGM says that "At SEGM's request, Medscape withdrew its inaccurate coverage of the study" it describes as a key study claiming that "gender-affirmative" surgeries improve mental health outcomes, and that Medscape "is currently in the process of notifying over 6,000 clinicians who took its Continued Medical Education (CME) class that the original conclusions of the study were incorrect". This is SEGM's own account of its work; the page does not name the study or Medscape's course (32). The same letter says SEGM "formed in early 2020", that "more than 120 clinicians and researchers" had joined it, and, on legislation, that bills treating psychotherapy for gender dysphoria as conversion therapy "fetter the clinical freedom of ethical clinicians" (SEGM's words). Its stated goals for 2021 include publishing "practice guidance" and continuing "engagement with medical societies" and with "legislators and policy makers".
  • Origins as the sources give them: SEGM's About page says SEGM "was formed in response to a proliferation of treatment guidelines" and gives no year (25, read); the letter above says it "formed in early 2020"; Undark reports that Malone "co-founded" it in 2019 (see People on file). The IRS exemption for the filer (EIN 84-4520593) is listed as "issued: March 2021" (ProPublica Nonprofit Explorer, 2, read). The date of the exemption is not the date of incorporation, and the sources cited give no incorporation date.
  • 2020 onward: a media item republished on SEGM's own site (dated there 4 August 2023; the outlet is not named in the page text) reports on the American Academy of Pediatrics' decision to commission a review of the evidence on youth gender care. It says Julia Mason, a pediatrician, "co-founded a group called the Society for Evidence-Based Gender Medicine" and that "Since 2020, she said, she has unsuccessfully lobbied the academy's leadership to commission a systematic review." The lobbying claim is Mason's own statement as the item reports it; the page names no document or meeting. Mason is the founding board member listed on SEGM's About page and a director on its filed returns (109, read; 25, read).
  • 2021-07-07 (SEGM post of 2021-08-09): SEGM filed an amicus brief in the United States Court of Appeals for the Ninth Circuit, No. 21-15668, supporting affirmance in favour of the defendant-appellee, an Arizona state health-care cost-containment official, in an appeal brought on behalf of minors. The brief's cover gives its date as 7 July 2021 and its author as "Society for Evidence Based Medicine" (as printed), with a law firm as counsel (Cohen Dowd Quigley P.C.). SEGM's post, headed "Mastectomy for Minors: SEGM Challenges WPATH's Position of 'Proven' Safety, Efficacy, and Medical Necessity", says the brief challenges the position of WPATH and the Pediatric Endocrine Society's amicus brief that mastectomies for gender-dysphoric adolescents are evidence-based, and says psychotherapy "rather than hormones and surgery, must be the first-line treatment for all gender-dysphoric youth". The same post says SEGM "recognizes the right of mature adults to undergo 'gender-affirming' interventions"; the brief's own table of contents has a section arguing that "the rationale for gender transition in minors was to improve suboptimal transition outcomes of mature adults" and one on adult surgery evidence, so its argument reaches adults. This is anti-trans rhetoric presented as evidence review; the evidence brief records that low certainty is common across pediatric medicine and that randomized trials are widely considered unethical. The brief is the only document of the case cited here (110; brief 111; read).
  • 2021-12-08: SEGM posted a summary of an article by David Schwartz, Ph.D., a psychologist, titled "Clinical and Ethical Considerations in the Treatment of Gender Dysphoric Children and Adolescents: When Doing Less Is Helping More". SEGM's subtitle reads "Psychologist advocates for psychotherapy rather than pharmacological and surgical interventions"; it calls his approach "a welcome and safe alternative to 'affirmative care'" and says he presents "a thoughtful, cogent, well-researched case for making psychotherapy the first-line treatment" (112, read). The page does not name the journal or give the article's own date. SEGM's promotion of psychotherapy in place of gender-affirming care is anti-trans rhetoric; the evidence brief documents the case for care.
  • 2021 to 2026: PubMed lists ten journal items (letters, comments, reviews and articles) in which an author's affiliation line is the Society for Evidence-Based Gender Medicine, Twin Falls, Idaho. They include: a 2021 letter in Archives of Sexual Behavior "in support of psychotherapy for gender dysphoria" (113); a 2022 article in the Journal of Sex & Marital Therapy titled "Reconsidering Informed Consent for Trans-Identified Children, Adolescents, and Young Adults" (114); a 2023 critique of the Dutch youth studies in the same journal (115); a 2023 letter, "The Detransition Rate Is Unknown," in Archives of Sexual Behavior (116); a 2023 letter in Psychiatry Research (117); a 2025 article on the Cass Review and the law in Archives of Disease in Childhood, written with authors from other institutions, one of them a former president of the Royal College of Paediatrics and Child Health (118); a 2025 article on critiques of the Cass Review in the Journal of Sex & Marital Therapy (119); a 2025 review on estrogen with an author affiliated with Genspect (120); and a 2026 piece in the International Journal of Psychoanalysis (121). The listing shows where the body's affiliated authors publish; it does not show that the body as an organization commissioned each paper. (PubMed records)
  • 2022-04-25: a meeting with HHS Office for Civil Rights and OMB officials, arranged by William Malone, per Transgender Map (attributed to that site).
  • 2022-10-03 (posted 2022-10-31): SEGM's comment on the proposed Section 1557 rule (docket HHS-OS-2022-0012) opposed a rule that would require coverage of "medically necessary gender affirming care", argued that gender-affirming care at best counts as an "innovative medical practice", and said regulations requiring it "should not be adopted". The comment cites the trend in some countries to restrict hormones and surgery for minors (122).
  • 2023-10: SEGM's own page for its first conference, "International Perspectives on Evidence-Based Treatment for Gender-Dysphoric Youth" (123), is headed "October 2023, New York, NY" and says SEGM hosted the conference and that it "featured more than 30 experts" from Australia, Belgium, Canada, Finland, France, Germany, Norway, Sweden, the United Kingdom and the United States. The page gives the welcome and opening remarks to "Dr. Roberto D'Angelo, SEGM President 2023" and the closing remarks to "Dr. William Malone, SEGM Board Member", and carries a section headed "SEGM 2023 Conference Speakers" with an embedded speaker list. SEGM's file of speakers titled "SEGM Conference 2023 Speakers" (headed "Speakers" and "Experts in Gender Dysphoria"; 124) states in its entry for Roberto D'Angelo that he "serves as the President of SEGM" and, in its entry for William Malone, that "in 2018" he "helped form the Society for Evidence-Based Gender Medicine". The file prints no date or place; its title carries the year. The conference is part of SEGM's anti-trans campaign against gender-affirming care.
  • 2023-12-26 and 2024-02-01: SEGM published two posts criticising the World Health Organization's plan to develop guidelines for "trans and gender diverse" people: "The World Health Organization Announces Transgender Guideline Plans" (26 December 2023, updated after WHO's announcement of 15 January 2024) and "The World Health Organization Clarifies its Plans to Issue Guidelines on Trans and Gender Diverse People—Significant Concerns Remain" (1 February 2024). The second says the guideline development group had members whose organizations promote wide access to hormones and legal recognition of self-determined gender, and that "all but four" members "appear to have significant conflicts of interest" (SEGM's words). A media item SEGM lists, dated 2024-02-01 and quoted on its own page, calls the second post SEGM's "second letter" to WHO and quotes it as expressing an "overarching concern that the WHO may be inadvertently involved in the production of a biased guideline." (125; 126; 127; read).
  • 2024-02-01: SEGM's post on the WHO's January 2024 announcement, with comments due 2024-02-02, welcomes the WHO's statement that its hormone recommendations would not cover children and adolescents, and objects to the rest: it says the WHO "signals that it will recommend expanded hormone availability and legal recognition of self-determined gender for all others", calls both "contested notions", and says the "question of legal recognition of self-ID should be decoupled from the current scope", on the ground that it affects "the rights of women" and the guideline group "includes no voices representing the rights of women". These are SEGM's statements of its position on legal recognition of gender; framed as protecting women and girls, the argument is made against the WHO taking up legal recognition of people's gender at all (126, read).
  • 2024-07-11: SEGM published "WPATH Influence Undermines WHO's Transgender Guidelines", saying the WHO's June 2024 addition of six members to its guideline group leaves it "unbalanced and heavily influenced by transgender activist groups" and that its scope "continues to be wide, conflating medical and legal issues". It tells the WHO it renewed its objection to the group's make-up in light of documents unsealed in Boe v. Marshall, which SEGM says show that WPATH acted to keep unfavourable evidence reviews of hormones from being published (SEGM's account of the court documents). The post also repeats SEGM's objection to guidance promoting self-identification of gender in legal settings (128, read).
  • 2024-09-03: files an amicus brief in United States v. Skrmetti arguing that the evidence for current youth treatments is limited; InfluenceWatch describes it as neutral on the Tennessee law itself. A brief that stresses weak evidence while taking no side was filed in a case about a ban on care.
  • 2024-10-30: an item on SEGM's home page (excerpted from reporting, listed under "SEGM in Media" with that date) says "Letters to WHO" from SEGM and from the Clinical Advisory Network on Sex and Gender (CAN-SG), "a network of mainly UK and Irish clinicians", questioned whether WHO would evaluate the benefits and harms of hormonal treatments for gender incongruence. The excerpt describes letters from the two bodies, not one joint letter (62, read).
  • 2024-12-22: SEGM posted its reproduction of The Economist's article of 2 December 2024 (described in the entry for Glenna Goldis under People on file; 31, read). The article quotes Elspeth Cypher, "a former justice on the Supreme Judicial Court of Massachusetts", as saying that giving oestrogen to a boy who identifies as a girl is "like saying you should give a boy a hysterectomy" (a comparison that equates a hormone treatment with surgery). It also quotes her saying that a Supreme Court ruling in Tennessee's favour "would become a tie. My biology trumps your internal feelings, and vice versa". Both statements are anti-trans rhetoric. Cypher's own role is at the Women's Liberation Front, where its staff-and-board page lists her as President for 2025-2028 (129, read). The reproduction is SEGM's choice of an article. SEGM's own conference page also lists her, as "Hon. Elspeth B. Cypher, Massachusetts Supreme Judicial Court Justice (ret.)", a speaker on the panel "When Science and Law Intersect" (Thursday 5 November 2026, 16:15), a programme listing (SEGM, Washington conference programme for 5–7 November 2026).
  • 2024-12-30: in its year-in-review page, SEGM lists "Providing open-access fees for publications" among its 2024 activities: it says it "continued its longstanding tradition of funding open-access fees for a number of publications that debate the practice of youth gender transition, making them accessible to everyone" (SEGM, 130, read; SEGM's own description, no amounts, journals or papers named on that page). The same page says SEGM commissioned systematic reviews from "an expert team from a world-renowned research university" without naming it, and that it submitted a brief it describes as "neutral" as amicus to the U.S. Supreme Court in the case heard on 4 December 2024.
  • 2024-12-30: SEGM's year-in-review page of 30 December 2024 says that in 2024 its efforts were "recognized in The New York Times by journalist and columnist Pamela Paul who described SEGM as" "one of the most reliable nonpartisan organizations dedicated to the field" (130, read; SEGM's own account of the praise). The praise is SEGM's selection of a columnist's words and does not make its campaign against care good faith. The page links the New York Times opinion newsletter entry of 30 January 2024 (131).
  • 2024: commissions systematic reviews (InfluenceWatch reports five reviews commissioned in 2024, one published and four in progress as of mid-2025, and names McMaster only for the one review funded by the 2023 Edelman grant; Transgender Map reports five McMaster reviews per SEGM's 2023 IRS filing). Transgender Map says McMaster announced in 2025 that it would no longer accept SEGM funding (not independently verified).
  • 2025-05-30: SEGM's Digest Issue 1, on the mastectomy systematic review published in Plastic and Reconstructive Surgery (2025, 155(6), 915-923), says the authors disclosed "that the review was funded by the Society for Evidence-Based Medicine (SEGM) through a multi-year research agreement between McMaster University and SEGM" (SEGM, 132, read; SEGM's own summary, the wording "Society for Evidence-Based Medicine" is as printed). This adds a research agreement with McMaster University to the existing link between McMaster and the Edelman Family Foundation grant purpose; the page gives no amount or term.
  • 2025-07-07: SEGM's Digest, Issue 2 (June 2025), published on its own site, summarizes United States v. Skrmetti as the Supreme Court having "ruled 6-3 ... to uphold Tennessee's Senate Bill 1" and ends the summary: "With this ruling, laws passed in more than 20 states imposing age-based restrictions are now likely to take full effect." Under a heading for the case it adds "SEGM comment: The Skrmetti decision affirms states' authority to regulate pediatric gender medicine." The same comment says "red states" are "banning the practice" and that the way out of polarization is "to treat pediatric gender transition as a medical intervention, not a civil rights issue" (read on the page, 133). The comment also warns of "regulatory fragmentation", with states split between banning the practice and sanctuary policies, and of youth "in limbo"; it offers no objection to the ruling itself.
  • 2025-09-10: responds to the Southern Poverty Law Center's designation of SEGM as an anti-LGBTQ hate group (InfluenceWatch and Transgender Map).
  • 2025-09-10: SEGM's own response to the Southern Poverty Law Center, "Our Response to the Southern Poverty Law Center", says the SPLC put it on its "hate map" in early 2024 and "categorically rejects" the allegations. It disputes the SPLC's statement that "SEGM members and advisers filed a petition with the U.S. Food and Drug Administration (FDA) calling for an end to prescription puberty blockers for trans kids" as "a misrepresentation of facts", and quotes the petition as asking the FDA to "fulfil its public health mission by commissioning a comprehensive analysis of existing studies concerning this use, by seeking new, long-term studies of this use, [and] by promoting awareness of the state of evidence concerning this use." SEGM does not deny in that passage that members and advisers filed the petition; it disputes the SPLC's description of what the petition asked. The response also says "SEGM has never endorsed bans on youth gender medicine" and "is not a policy-making body". It denies the SPLC's allegation that it was funded by the Koch Institute, stating that "an in-depth investigative report" showed the alleged "problematic funding" came from "a lifelong Democrat, feminist, and philanthropist"; the page names neither the report nor the donor (SEGM's statement, not independently established; whether the donor SEGM describes is any funder in the filings is not established). It adds that since 2023 SEGM has been "partnering with renowned universities to conduct research" and "securing accreditation for continuing medical education". SEGM's description of its work as "genuine unknowns" is the organization's framing and does not make its campaign good faith (134, read).
  • 2025: SEGM's CME page says the series "International Perspectives on Evidence-Based Treatment for Gender Dysphoric Youth" (seven modules, initially approved 2 June 2025) was accredited "through the joint providership of the Washington State University Elson S. Floyd College of Medicine (WSU) and the Society for Evidence-Based Gender Medicine (SEGM)". On 29 October 2025 SEGM "was notified" that the ACCME was conducting an inquiry into the accreditation of the seven modules; WSU told SEGM it had been asked to suspend learner access for the duration and removed the courses from its CloudCME platform, and SEGM says the videos remain publicly available without credit (SEGM, 135, read; SEGM's own account).
  • 2025-10-02: SEGM reproduces, with permission and a translation approved by the author, a WELT article by Anna Kröning on "wanted"-style images circulated of participants in SEGM's Berlin conference, and on a statement by the German Medical Association's president condemning them (56, read).
  • 2025-10-29: the Accreditation Council for Continuing Medical Education opens an investigation of a Washington State University course designed by SEGM; the university says it will suspend the course (InfluenceWatch; it notes its account relies partly on the Daily Signal and Erin in the Morning).
  • 2026-02-05: publishes a post endorsing the American Society of Plastic Surgeons' February 2026 recommendation to delay gender surgery to at least age 19, says it hopes other medical bodies "follow suit", and writes that young adults could face a higher threshold for irreversible interventions (136).
  • 2026-02-05: further statements in SEGM's post on the American Society of Plastic Surgeons' February 2026 position statement: under "Potential implications" the post says "Medical malpractice litigation may face fewer barriers", argues that ASPS's recommendation "will likely intensify scrutiny of clinicians who continue operating on minors", and cites "a recent New York jury award of $2 million in a malpractice case over a mastectomy at 16" (SEGM's statement, not checked against a court record). The same section says "Malpractice carriers could raise premiums" and that young adults "could face a higher threshold for irreversible interventions". SEGM lists these as likely consequences of the statement (136, read).
  • SEGM's FAQ says "SEGM was the first English-language website to translate and disseminate the Finnish, Swedish, and French position statements and treatment guidelines updates regarding pediatric gender medicine" (SEGM's own claim, in its answer on the accuracy of its site; 16). Its 2026-02-05 post says SEGM "translated the full Finland's PALKO/COHERE recommendations" and was "the first organization to report that Finland broke with WPATH" (own claim; 136). The FAQ's account of "What does SEGM do?" lists, as its "core mission", "the evaluation and dissemination of evidence"; the translations are named in the accuracy answer, not in that list. The same FAQ says SEGM "provides grants to individual researchers and research organizations" and pays "open access fees for publications in scientific peer-reviewed journals"; SEGM's filed returns show one grant-paid row ($10,000 to United Charitable, see Money given), and the FAQ names no recipient or amount. It says SEGM "is not a membership organization" and has "no political or religious affiliations". SEGM's contact page says: "SEGM provides grant funding to support research and systematic reviews related to youth gender medicine. Grant applications are accepted on a rolling basis." Clinicians and researchers are invited to apply; the page states no amounts and names no other funder (137, read).
  • April 2, 2026: SEGM published an appraisal it commissioned of the Utah Department of Health and Human Services' May 2025 evidence review, which SEGM's summary describes as having concluded that puberty blockers and cross-sex hormones are safe and effective and that the pathway should stay open. The SEGM summary concludes: "Since the Utah Review does not contain systematic evidence reviews, it cannot serve as a reliable basis for evidence-based decision-making." and urges that "Healthcare policymakers should accept the findings of existing high-quality systematic reviews", listing the HHS review among them. (The "Utah Review". A Methodological Appraisal, Executive Summary, April 2, 2026, pp. 2 and 5; 138) The full report's conflict-of-interest page says "This analysis was commissioned by SEGM. EA and YZ contributed to the U.S. Department of Health and Human Services Report on pediatric gender dysphoria." (full report, p. 4; 139) The sentence is quoted to show that the appraisers of one government review had contributed to another that SEGM endorses.
  • 2026-04-17: the Dave Yost for Ohio campaign's report lists a $300,000 payment to a payee matching SEGM by name, city and state (see Money received).
  • September 21, 2026 (revised October 2): at the request of Genspect Portugal, SEGM sent the Portuguese Parliament a rebuttal of claims made against restrictions on blockers and hormones. It says "e) In sum, there is no evidence that bans or restrictions on PB or CSH for the pediatric population increase suicide risk." (p. 5) and, on regret, "Response: This statement is misleading. Studies already report up to 30% of medical detransition rates among teens within a relatively short timeframe, painting a more complex picture." (p. 9; SEGM submission, 140) Against this the evidence brief reports 98% (704 of 720) still on hormones in the Dutch cohort, pooled surgical regret of 1% across 27 studies (7,928 patients), regret most often following lack of social support, and a 2026 rapid review linking restrictive policies to poorer mental health. The submission itself says it takes "no statement in support of or against the proposed Bills" (p. 1).
  • 2026-10-08: a foreign nonprofit corporation record for SEGM was formed in the District of Columbia, status "Active - In Good Standing" (District of Columbia business registry). SEGM's own page gives the dates of its Washington, DC conference as 5 to 7 November 2026 and describes it in the past tense (SEGM, Washington conference programme for 5–7 November 2026); Transgender Map (an advocacy site) had reported the dates as announced.
  • The report's 2026 sibling, "Wolves in White Coats", cites SEGM's page "Fact-Checking the HHS, `Gender-Affirming Care and Young People' contains a number of errors and misrepresentations" in footnote 114, against HHS's 2023 document (the web address is cut at a line break in the PDF text) (report PDF, footnotes (text extracted from the PDF)).
  • The Supreme Court's slip opinion in United States v. Skrmetti, No. 23-477, decided 2025-06-18, cites SEGM's brief once, in Justice Alito's opinion concurring in part and in the judgment (slip op. at 20 to 21): for the statement that "a person who is transgender now may not be transgender later" it adds "see also Brief for Society for Evidence-Based Gender Medicine as Amicus Curiae 19-25 (discussing the rates of desistance among transgender youth)". The opinion of the Court (Chief Justice Roberts) does not cite the brief; the opinion cites SEGM nowhere else. The page says SEGM filed "in support of neither party" and that it takes no policy position; its brief was used in a separate opinion for an argument against heightened scrutiny of laws that single out trans people. The desistance framing is anti-trans rhetoric; the evidence brief reports 98% (704 of 720) still on hormones at follow-up in the Dutch cohort. [Supreme Court of the United States, No. 23-477 (text extracted from the PDF)]
  • SEGM's own statement on the final HHS report (page titled "US Department of Health and Human Services releases final report on youth gender dysphoria", its address marking it as the November 2025 release; the day is not shown on the page) says Evgenia (Zhenya) Abbruzzese, "co-founder and senior advisor to SEGM", "served on this interdisciplinary team in her individual capacity"; says "evidence alone does not dictate clinical or policy decisions" and that the HHS review supplies a "formal bioethical analysis" weighing the benefits and harms of "pediatric gender transition"; and says "We look forward to sharing our analysis of the final HHS report in a future Spotlight." [141
  • Ohio Supreme Court No. 2025-0472, status: Whether a decision will cite SEGM or the Center's brief cannot be answered until an opinion issues.
  • Ohio Supreme Court No. 2025-0472, status on 2026-11-12: The Court News Ohio preview (9) lists, on the state's side, a joint brief of the Independent Women's Forum and Center for Christian Virtue and a joint brief of Alabama and 24 other states; it does not mention SEGM.
  • 2023, conference speaker list: the file SEGM titles "SEGM Conference 2023 Speakers" (124, accessed 2026-11-14) lists Anna Hutchinson, DClinPsy (UK), among its "Experts in Gender Dysphoria", described as "Clinical psychologist with extensive experience in working with gender dysphoric minors, and a whistleblower on unsafe practices at the Tavistock's Gender Identity Development Service (GIDS)". The file prints no conference date or place in its text; the year is the one in SEGM's own title for the file. SEGM is an anti-trans body whose conference speaker lists present campaigning as clinical expertise; the listing is an appearance as a speaker.

Conferences and events on SEGM's own pages

  • SEGM's page for its 2025 conference, "Youth Gender Distress: Evidence, Etiologies, Ethics, and Psychotherapy", gives the dates 11 to 14 September 2025 and the place Berlin, Germany; says it had "over 40 speakers" from "more than 20 countries"; says the conference "has been endorsed by the International Association of Child and Adolescent Psychiatry and Allied Professions (IACAPAP)"; and lists opening remarks by Roberto D'Angelo and a welcoming address by Klaus Reinhardt (the page prints "Dr." and gives no role). Its agenda days are headed Evidence, Etiologies, Ethics and Psychotherapy; the keynote is by Kathleen Stock (26, read).
  • The same page lists SEGM's earlier conferences and other events: 2024, "Psychotherapeutic Approaches", Athens, Greece ("Questioning Gender" conference, 19 countries); 2023, "International Perspectives", New York City. Under "Other Events": a June 2024 conference in Paris co-sponsored with L'Observatoire La Petite Sirene, "The child at the centre of anthropological change: Can the child still grow up?"; June 2023, a conference at Tampere University, Finland, organised in partnership with Riittakerttu Kaltiala on "psychotherapeutic approaches to youth gender dysphoria"; and summer 2025, five symposia SEGM says it helped organise at the European Society for Child and Adolescent Psychiatry conference in Strasbourg, France, in collaboration with the ESCAP Policy Division (26, read).
  • SEGM's page for its 2026 conference gives the title "Rethinking Youth Gender Medicine: Charting a Path Forward", the dates 5 to 7 November 2026 and the place Washington, DC, and describes the event in the past tense ("brought together"). It adds to the 2026 entries, under other events, seven symposia on pediatric gender dysphoria at the IACAPAP congress in Hamburg, Germany, in July 2026, at which "SEGM advisors presented on several panels" (SEGM, Washington conference programme for 5–7 November 2026). SEGM's own page gives the dates. It lists "SEGM | CAN-SG 2026 Conference in London" among previous conferences (SEGM, Washington conference programme for 5–7 November 2026).
  • SEGM's London page, "Rethinking Youth Gender Medicine: First Do No Harm", announces a conference in Central London jointly organised with the Clinical Advisory Network on Sex and Gender (47, read). The page gives no date or year (the address carries "2026"), lists a two-day programme, and names Dr Louise Irvine and Dr Stella Kingett as co-chairs of CAN-SG. Speakers listed include Zhenya Abbruzzese, Prof. Michael Biggs, Prof. Alex Byrne, Dr. Alison Clayton, Prof. Alice Sullivan, Dr. Stephen Levine and Stephanie Davies-Arai.
  • Speakers at the Washington, DC conference named on SEGM's page include: Barrett Bowdre, listed as "Solicitor General, Alabama Office of the Attorney General"; Leor Sapir, "Senior Fellow, Manhattan Institute", who moderates the first-day session "When Science and Law Intersect" (its speakers are given above); Scot Glasberg, "Past President, American Society of Plastic Surgeons", with the talk "Breaking the Mold: How the American Society of Plastic Surgeons Decided to Put Evidence First" and as moderator of a panel of HHS evidence review authors; and Paul Terdal, "Health Consumer Advocate; Visiting Fellow, Do No Harm". Roberto D'Angelo is listed as "President, SEGM" and Will Malone as "Co-Founder, SEGM". A listing as a speaker is an appearance; it is not a statement of any body's role in the conference. See the profiles of the Manhattan Institute for Policy Research and the Child & Parental Rights Campaign (SEGM, Washington conference programme for 5–7 November 2026).
  • SEGM's page for the Washington, DC conference lists more than forty speakers (41 names shown) (SEGM, Washington conference programme for 5–7 November 2026). A speaker listing is an appearance, not a role in SEGM.

Evidence that the "evidence-based" and protective framing is pretextual

  • Adults in scope: SEGM's FAQ says its "specific focus is on care received by children, adolescents, and young adults" (16). Its February 2026 post says young adults could face a higher threshold for irreversible interventions, which parallels the bills (Texas HB 4754 and others) that treated anyone under 26 as a child.
  • Policy disclaimer against conduct: the FAQ says SEGM "is not a policy-making body" and "has not endorsed any policies" restricting youth transition, yet it files briefs in a ban case, meets federal officials, and a Republican gubernatorial campaign committee's report lists a $300,000 payment to a payee matching SEGM by name, city and state.
  • Comparisons: Transgender Map reports that SEGM's website compares youth gender medicine to thalidomide, lobotomies and the opioid epidemic (not independently verified). That frames care as a scandal, not a disagreement about evidence.
  • SEGM describes its remit as extending past childhood. Its Supreme Court brief calls it "a non-profit professional association promoting safe, compassionate, ethical, evidence-based healthcare for children, adolescents, and young adults with gender dysphoria", and its 2026 submission to the Portuguese Parliament says it is "dedicated to advancing rigorous scientific evaluation of clinical practices affecting children, adolescents, and young adults with gender incongruence/gender dysphoria (GI/GD)." (Brief of SEGM, United States v. Skrmetti, No. 23-477, Sept 3, 2024, pdf p. 14 / printed p. 1; SEGM submission, Oct 2, 2026, p. 1; 140) The same brief states it is filed "in support of neither party" while asking the Court to see the evidence as "low-quality"; the evidence brief records that low certainty is common across pediatric medicine and that randomized trials are widely considered unethical.
  • In its brief of 2024-09-03 in No. 23-477, SEGM asserts a claim about adult care: "The very rationale for transitioning children is due to the observations that gender transition in adults failed to yield the intended positive outcomes." (p. 16). The sentence is reported as SEGM's assertion; it reaches adult transition and is made in a brief that says it takes no side on the law. Case status: The Supreme Court decided United States v. Skrmetti on 2025-06-18, affirming the Sixth Circuit's ruling that upheld Tennessee Senate Bill 1; the brief suggested affirmance. (Brief of Amicus Curiae Society for Evidence-Based Gender Medicine (SEGM) in Support of No Party but Suggesting Affirmance, Supreme Court of the United States, No. 23-477, 2024-09-03, p. 16)
  • Adults in scope, 2023: in a critical analysis of a Dutch clinic's "20-year" study, published on its own site (2023-02-02), SEGM writes that the study "does not address trends in 18-25-year-old gender-dysphoric youth", calls that group "highly vulnerable", and says "Future research should move beyond the somewhat arbitrary cut-off of age 18, analyzing the entire population of gender-dysphoric young people 25 and younger." SEGM thus calls for future research to analyze everyone 25 and younger, a year before its 2024 posts to the WHO (142, read). The same reach appears in SEGM's 2024-02-01 post on the World Health Organization, which says "the vulnerable group of young adults <25 years is still in scope" of the WHO's planned guideline (126, read).
  • The disclaimer against policy sits beside SEGM's own writing on the laws. Its Digest of 2025-07-07 presents the Skrmetti decision as affirming "states' authority to regulate pediatric gender medicine" and notes that laws in more than 20 states "are now likely to take full effect" (133). Its FAQ says SEGM "has not endorsed any policies, including those that pose various restrictions on hormonal or surgical transitions of minors" while saying "the regulation of medicine is a core and necessary function" (16).
  • SEGM's post of 2026-02-05 on the American Society of Plastic Surgeons statement (136) does not mention a law or a ban. It says the statement "is precisely what SEGM has advocated for since our inception", that SEGM is "proud to have supported this shift through focused work since 2019", and "It is our sincere hope that other medical organizations follow suit". It also says "young adults could face a higher threshold for irreversible interventions". The page therefore praises a professional society's recommendation (delay of surgery to at least age 19), not a ban, so it is evidence of SEGM's campaign aim and not of a breach of the "never endorsed bans" statement.

What the records don't show

Filed officers (Society for Evidence-Based Gender Medicine Corp, EIN 84-4520593; all $0 on each return, TY2020, TY2022, TY2023, TY2024): Roberto D'Angelo, President; William Malone, Secretary; Stephen Beck, Treasurer, who SEGM's open letter of December 19, 2020 also lists among the Board of Directors (32); Julia Mason, Director; Marcus Evans, Director (TY2020 return only). Source: IRS Form 990 e-file, EIN 84-4520593, objects 202133199349322848 (TY2020), 202323179349310692 (TY2022), 202423189349302147 (TY2023), 202513209349300536 (TY2024), ProPublica Nonprofit Explorer, 2.

Open questions

  • Who the underlying donors of the donor-advised-fund sponsors are: not disclosed and not established; SEGM's returns in the records carry no donor rows and the sponsors' returns show grants only.
  • Why the Dave Yost for Ohio campaign's report lists a $300,000 payment to a payee matching SEGM on 2026-04-17: the report shows the payment and six others of the same date (see Money received) but no purpose beyond "CONTRIBUTION"; no statement, news report or ethics guidance is cited. The committee's last report in the files is the Semiannual (July) 2026 report; the next, the 2026 Annual, is due 2027-01-29; SEGM's Form 990 for the year ending 2026-12-31 is due 2027-05-15 unless extended.
  • Whether the committee's seven same-day payees are the organizations matched by name (none carries an identifier; the Ethics and Public Policy Center, SEGM and Wisconsin Institute for Law & Liberty rows match their IRS records by city and state, the Do No Harm row's Utah location differs from its IRS record, the True North Legal row matches True North Legal PLLC (EIN 92-2096361, a disregarded entity of Minnesota Family Institute) and the organization's own statement that it is an initiative of Minnesota Family Council by name and city only, the Founding Freedoms Law Center row matches the organization's own statement that it is the legal arm of The Family Foundation (Virginia) and a Virginia registry former name by name only, and the Freedom Foundation row's Salem OR post office box is the mailing address in Oregon's registration of the body recorded as Evergreen Freedom Foundation, EIN 94-3136961, Olympia WA (the footer of freedomfoundation.com reads "REGISTERED 501(C)(3). EIN: 94-3136961", and ProPublica Nonprofit Explorer lists that EIN as Evergreen Freedom Foundation, Olympia, WA); the Freedom Foundation's own site search for "transgender" returned no results when read). The comparison of the rows' business addresses with filed addresses is given under Money received: the Ethics and Public Policy Center and SEGM rows match on every return; the Wisconsin Institute for Law & Liberty row on its master-file record and 2025 return only; the Freedom Foundation's Salem, OR post office box is unconfirmed; the Do No Harm row agrees with that body's own published Salt Lake City mailing address, not its IRS record.
  • Which sponsored project of the Edward Charles Foundation directed the $100,000 gift of TY2021 (the return's grant row gives only the purpose "CHARITABLE GIFT").

Information packet: the full written profile, every claim, table and source, to read, print or save as PDF.

Sources

  1. image page: https://en.wikipedia.org/wiki/Society_for_Evidence-Based_Gender_Medicine
  2. https://projects.propublica.org/nonprofits/organizations/844520593
  3. https://truenorthlegal.org/
  4. https://www.foundingfreedomslaw.org/about
  5. https://data.oregon.gov/resource/tckn-sxa6.json?registry_number=113094692
  6. https://www.opb.org/news/article/labor-unions-oregon-janus-decision-freedom-foundation/
  7. https://nationalnewswatch.com/2025/05/16/ohios-republican-attorney-general-suspends-his-campaign-for-governor-after-trump-backed-a-rival
  8. https://codes.ohio.gov/ohio-revised-code/section-3517.109
  9. https://courtnewsohio.gov/cases/previews/26/0324/0324.asp
  10. https://www.influencewatch.org/non-profit/society-for-evidence-based-gender-medicine/
  11. https://web.charityengine.net/fflc
  12. https://www.ohiosos.gov/campaign-finance/
  13. https://projects.propublica.org/nonprofits/organizations/376624335
  14. https://www.edwardcharlesfoundation.org/
  15. https://projects.propublica.org/nonprofits/organizations/264245043/202230329349301233/full]
  16. https://segm.org/faq
  17. https://projects.propublica.org/nonprofits/organizations/844520593]
  18. https://www.irs.gov/charities-non-profits/annual-exempt-organization-return-due-date]
  19. https://codes.ohio.gov/ohio-revised-code/section-3517.109]
  20. https://donoharmmedicine.org/contact/
  21. https://www.freedomfoundation.com/]
  22. https://pdf.guidestar.org/PDF_Images/2023/376/624/2023-376624335-202423209349103907-.pdf
  23. https://apps.irs.gov/pub/epostcard/cor/376624335_202312_990PF_2025011022985672.pdf
  24. https://segm.org/studies
  25. https://segm.org/about_us
  26. https://segm.org/Berlin-2025
  27. https://link.springer.com/article/10.1007/s10508-022-02472-8
  28. https://segm.org/Placebo-effects-of-gender-affirmative-care
  29. https://segm.org/Cass_Integrity_Project_Yale
  30. https://undark.org/2024/05/20/pediatric-transgender-care-contentious-segm/
  31. https://segm.org/A_big_transgender_rights_case_heads_to_America%E2%80%99s_Supreme_Court
  32. https://segm.org/2020_gender_medicine_highlights_SEGM
  33. https://kevinmd.com/2019/10/a-physician-is-worried-about-gender-transition-in-pediatrics.html
  34. https://genspect.substack.com/p/the-best-of-genspect-the-duplicity
  35. https://www.thefp.com/p/doctor-silenced-gender-medicine
  36. https://www.plymouth.ac.uk/staff/richard-byng
  37. https://doi.org/10.3399/bjgp19X701909
  38. https://researchportal.plymouth.ac.uk/en/publications/gender-incongruence-in-children-adolescents-and-adults/
  39. https://sarahmittermaier.substack.com/p/online-trans-communities-as-zero
  40. https://doi.org/10.1210/clinem/dgab205
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC8277208/
  42. https://segm.org/Keira_Bell_ruling_global_repercussions
  43. https://segm.org/UK_shuts-down-worlds-biggest-gender-clinic-for-kids
  44. https://segm.org/Trevor-project-laws-and-suicide-attempts-2026
  45. https://manhattan.institute/person/colin-wright
  46. https://segm.org/Berlin-2025/speakers
  47. https://segm.org/London-2026
  48. https://epub.ub.uni-muenchen.de/118198/
  49. Guideline report: https://register.awmf.org/assets/guidelines/028-014m_S2k_Geschlechtsinkongruenz-Geschlechtsdysphorie-Kinder-Jugendliche_2025-06.pdf
  50. McMaster University: https://experts.mcmaster.ca/scholarly-works/3996783
  51. Berlin programme, p. 8: https://www.dgppn.de/_Resources/Persistent/8c6d83d8aa792170b6fc6993fcff991ee31da769/20250911_youth%20gender%20and%20distress%20evidence_programm.pdf#page=8
  52. Webinar notice: https://can-sg.org/2025/10/06/are-academics-allowed-to-talk-about-sex/
  53. House of Lords, archived 19 June 2025: https://web.archive.org/web/20250619090024id_/https://hansard.parliament.uk/pdf/Lords/2025-04-24
  54. https://segm.org/UK-cross-sex-hormones-restriction
  55. Berlin programme, p. 10: https://www.dgppn.de/_Resources/Persistent/8c6d83d8aa792170b6fc6993fcff991ee31da769/20250911_youth%20gender%20and%20distress%20evidence_programm.pdf#page=10
  56. https://segm.org/media/listed-wanted-medical-association-condemns-harassment-scientists
  57. Genspect conference report: https://genspect.substack.com/p/dispatches-from-deutschland-a-conference?action=share
  58. Berlin programme, p. 11: https://www.dgppn.de/_Resources/Persistent/8c6d83d8aa792170b6fc6993fcff991ee31da769/20250911_youth%20gender%20and%20distress%20evidence_programm.pdf#page=11
  59. European society biography: https://www.escap.eu/escap-community/governing-board/maja-drobnic-radobuljac
  60. https://can-sg.org/about-us/
  61. Co-organizer’s booking page: https://www.tickettailor.com/events/clinicaladvisorynetworkforsexgender/2162461
  62. https://segm.org/
  63. University of Gothenburg: https://www.gu.se/en/research/affective-disorders
  64. https://www.dgppn.de/_Resources/Persistent/8c6d83d8aa792170b6fc6993fcff991ee31da769/20250911_youth%20gender%20and%20distress%20evidence_programm.pdf
  65. https://cme.utsouthwestern.edu/node/136418
  66. https://www.psy.ox.ac.uk/research/oxford-gender-and-wellbeing-research-group
  67. https://www.iacapap.org/news/global-perspectives-on-youth-gender-distress-segm-2025-conference-report.html
  68. https://www.therapyfirst.org/about/
  69. https://projects.propublica.org/nonprofits/organizations/873936604
  70. https://segm.org/treatment-of-young-people-with-gender-incongruence-requires-more-than-consent
  71. https://segm.org/unknown_gender_transition_regret_rate_adolescents
  72. https://www.timeshighereducation.com/news/puberty-blockers-researcher-shortlisted-maddox-prize
  73. https://www.drglasberg.com/
  74. https://www.plasticsurgery.org/documents/health-policy/positions/2026-gender-surgery-children-adolescents.pdf
  75. https://www.nbcnews.com/health/health-news/plastic-surgeons-group-delay-gender-affirming-surgery-age-19-rcna257607
  76. https://www.statnews.com/2026/02/03/gender-affirming-surgeries-delay-until-age-19-plastic-surgeon-association-says/
  77. https://www.tickettailor.com/events/clinicaladvisorynetworkforsexgender/1832482
  78. https://reason.com/wp-content/uploads/2025/01/adc327921.pdf
  79. https://segm.org/media/secret-support-researchers-under-attack
  80. Newspaper biography: https://www.faz.net/redaktion/thomas-thiel-200010209.html
  81. Institute biography: https://www.zi-mannheim.de/en/research/people/person/48.html
  82. https://projects.propublica.org/nonprofits/organizations/852892486
  83. https://resiliencehealth.network/committed-to-individual-health/
  84. https://genspect.substack.com/p/it-gets-worse
  85. https://www.broadview.news/
  86. https://lisaselindavis.com/
  87. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214157
  88. https://en.wikipedia.org/wiki/Rapid-onset_gender_dysphoria_controversy
  89. https://www.alabamaag.gov/attorney-general-steve-marshall-appoints-barrett-bowdre-as-alabama-solicitor-general/
  90. https://www.ftc.gov/news-events/events/2025/07/dangers-gender-affirming-care-minors
  91. https://www.ftc.gov/system/files/ftc_gov/pdf/Healthcare-Workshop-Speakers-July-9-2025.pdf
  92. https://childparentrights.org/news/attorney-vernadette-broyles-exposes-the-trans-assault-on-parental-rights-on-fox-news/
  93. https://segm.org/GIDS-puberty-blockers-minors-the-times-special-report
  94. https://www.psy.ox.ac.uk/people/kathryn-webb
  95. https://segm.org/Economist-HHS-gender-dysphroria-report
  96. https://segm.org/England-stops-gender-affirmation-of-minors-the-economist
  97. https://www.spiked-online.com/2018/11/30/we-are-experimenting-on-children/
  98. https://segm.org/gender-identity-conceptual-clarity
  99. Governor’s announcement: https://www.flgov.com/eog/news/press/2025/governor-ron-desantis-appoints-eight-board-medicine
  100. SEGM speaker biography: https://www.segm.org/washington-dc-2026/speakers
  101. Institute seminar programme: https://marshfieldresearch.org/2024-scientific-seminar
  102. Daily Nous: https://dailynous.com/2025/06/26/philosopher-wraps-cooperation-with-trump-in-flag-of-academic-freedom/
  103. The Tech: https://thetech.com/2025/07/10/alex-byrne-trans-report
  104. Letter to the regulators: https://can-sg.org/letter-to-pathways-trial-regulators-december-2025/
  105. Published letter: https://bps.org.uk/psychologist/time-honest-reflection-not-defence
  106. Book biography: https://www.perlentaucher.de/buch/anna-kroening/deutschland-hat-ausgelernt.html
  107. Writer’s biography: https://www.pamelapaul.com/bio/
  108. https://www.regulations.gov/comment/HHS-OCR-2019-0007-148044
  109. https://segm.org/media/medical-group-backs-youth-gender-treatments-calls-research-review
  110. https://segm.org/Mastectomies_for_minors_not_evidence-based
  111. https://segm.org/sites/default/files/Amicus%20Brief%20SEGM_2021.pdf
  112. https://segm.org/Psychotherapy_for_Gender_Dysphoric_Youth
  113. https://pubmed.ncbi.nlm.nih.gov/33089441/
  114. https://pubmed.ncbi.nlm.nih.gov/35300570/
  115. https://pubmed.ncbi.nlm.nih.gov/36593754/
  116. https://pubmed.ncbi.nlm.nih.gov/37308601/
  117. https://pubmed.ncbi.nlm.nih.gov/37263087/
  118. https://pubmed.ncbi.nlm.nih.gov/39401844/
  119. https://pubmed.ncbi.nlm.nih.gov/39903043/
  120. https://pubmed.ncbi.nlm.nih.gov/40506545/
  121. https://pubmed.ncbi.nlm.nih.gov/41524136/
  122. https://www.regulations.gov/comment/HHS-OS-2022-0012-73218
  123. https://segm.org/NYC_2023
  124. https://www.segm.org/sites/default/files/SEGM%20Conference%202023%20Speakers.pdf
  125. https://segm.org/world-health-organization-transgender-guidelines
  126. https://segm.org/WHO-TGD-Guideline-Concerns-2024
  127. https://segm.org/media/beleaguered-world-health-organization-wades-transgender-debate-and-met-uproar-over-plans
  128. https://segm.org/wpath-evidence-manipulation-risks-discrediting-WHO-transgender-guidelines
  129. https://www.womensliberationfront.org/staff-and-board
  130. https://segm.org/Gender-medicine-2024-summary
  131. https://www.nytimes.com/live/2024/01/30/opinion/thepoint
  132. https://segm.org/SEGM-Digest-Issue1-2025
  133. https://segm.org/SEGM-Digest-Issue2-2025
  134. https://segm.org/SPLC-SEGM-Response-2025
  135. https://segm.org/cme25
  136. https://segm.org/ASPS-position-statement-2026
  137. https://segm.org/contact_us
  138. https://segm.org/sites/default/files/2026-04/Executive%20Summary.pdf.
  139. https://segm.org/sites/default/files/2026-04/The%20%E2%80%9CUtah%20Review%E2%80%9D%20of%20Hormonal%20Treatments%20for%20Gender-Dysphoric%20Minors-A%20Methodological%20Appraisal_v1.3.pdf.
  140. https://segm.org/sites/default/files/2026-10/SEGM_submission_September_21_2026_submitted%20v2.pdf.
  141. https://segm.org/media/hhs-evidence-review-pediatric-gender-dysphoria-november-release]
  142. https://segm.org/20-years-of-the-Dutch-Protocol-critical-analysis